This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Persons encountering health services in circumstances related to reproduction
Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_CIRCUMSTANC_RELATED_REPRODUCTION
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
116050 |
4. Check minimum number of eventsNone |
116050 |
5. Include endpoints |
116050 |
6. Filter based on genotype QC (FinnGen only) |
116050 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z
Similar endpoints
↥List of similar endpoints to
Persons encountering health services in circumstances related to reproduction
based on the number of shared cases.
Similar with more cases:
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 116050 | 104298 | 11752 |
| Unadjusted period prevalence (%) | 32.48 | 35.55 | 5.18 |
| Median age at first event (years) | 31.82 | 31.05 | 38.58 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 14465
- Matched controls
- 126642
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z31.6
ICD-10 Finland
General counselling and advice on procreation
684.1
323.0
672
9
LGA21
NOMESCO Finland
Laparoscopic sterilisation by constriction of Fallopian tubes
1096.4
323.0
715
6
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
55.1
323.0
702
117
Z31.4
ICD-10 Finland
Procreative investigation and testing
867.0
323.0
2738
34
Z30.2
ICD-10 Finland
Sterilization
423.1
323.0
6504
244
Z31.5
ICD-10 Finland
Genetic counselling
16384.0
323.0
3926
*
KFD46
NOMESCO Finland
Bilateral vasectomy or ligature of vas deferens
771.9
323.0
4728
79
Z30.5
ICD-10 Finland
Surveillance of (intrauterine) contraceptive device
21.9
284.0
439
181
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
2058.9
235.8
240
*
N46
ICD-10 Finland
Male infertility
6.0
209.5
627
952
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
21.7
185.7
287
118
Z38.0
ICD-10 Finland
Singleton, born in hospital
783.3
171.4
177
*
TLC02
NOMESCO Finland
Simple extraction of IUD
11.3
166.4
332
262
W78
ICPC
Pregnancy
9.5
141.3
309
291
SPAT1380
SPAT
Postpartum check-up
261.6
137.1
147
5
Z39.2
ICD-10 Finland
Routine postpartum follow-up
135.3
136.7
153
10
SPAT1379
SPAT
Health check-up of pregnant person
13.8
131.0
238
153
LGA11
NOMESCO Finland
Laparoscopic sterilisation by destruction or division of Fallopian tubes
305.0
130.7
139
*
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
75.2
128.5
153
18
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
38.6
127.8
170
39
O80.0
ICD-10 Finland
Spontaneous vertex delivery
17.7
125.4
207
104
Z30.0
ICD-10 Finland
General counselling and advice on contraception
5.7
117.1
360
563
Z32.1
ICD-10 Finland
Pregnancy confirmed
34.6
103.7
141
36
MA3AE
NOMESCO Finland
Combined first trimester screening
+∞
103.0
104
*
TLC00
NOMESCO Finland
Insertion of intrauterine device
7.3
102.3
261
317
Z30.1
ICD-10 Finland
Insertion of (intrauterine) contraceptive device
4.9
96.6
336
607
115
Kela drug reimbursment
Breast cancer
2.5
96.3
859
3179
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
297.6
95.9
102
*
MA5AE
NOMESCO Finland
Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation
+∞
95.1
96
*
Z30.8
ICD-10 Finland
Other contraceptive management
8.0
94.6
227
251
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
95.3
93.5
108
10
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
174.5
90.3
99
5
WX307
NOMESCO Finland
Obstetric epidural analgesia
276.8
89.0
95
*
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
45.3
87.9
113
22
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
81.8
86.8
102
11
Z36.0
ICD-10 Finland
Antenatal screening for chromosomal anomalies
+∞
85.2
86
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
2.9
80.1
533
1660
Y13
ICPC
Sterilization male
18.1
79.2
129
63
SPAT1197
SPAT
Extensive health check-up of expecting family
3.6
76.9
378
946
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
354.7
76.8
81
*
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
139.1
71.0
79
5
L02BG04
ATC
letrozole; oral
2.4
70.1
639
2385
HAC20
NOMESCO Finland
Total mastectomy
2.9
69.9
449
1366
ZXA10
NOMESCO Finland
Bilateral
1.6
66.0
1893
10789
V252A
ICD-9 Finland
Contraceptive management, Sterilisation
0.4
65.4
284
6061
MA1AE
NOMESCO Finland
Ultrasound examination of early pregnancy (before 12. postmenstrual week)
20.5
64.2
100
43
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
2.4
62.8
580
2178
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
34.0
62.6
85
22
Z37.0
ICD-10 Finland
Single live birth
+∞
62.4
63
*
Z80.4
ICD-10 Finland
Family history of malignant neoplasm of genital organs
30.8
60.5
84
24
OAA11
SPAT
NA
62.6
58.5
71
10
L02BA01
ATC
tamoxifen; oral
2.9
55.8
372
1160
Z31.8
ICD-10 Finland
Other procreative management
508.4
55.7
58
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
2.2
55.6
587
2351
MAX99
NOMESCO Finland
Assistance to normal delivery
261.0
55.2
59
*
Z31.2
ICD-10 Finland
In vitrofertilization
+∞
54.4
55
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
0.5
52.9
330
6181
HA1AA
NOMESCO Finland
X-ray mammography
2.1
51.6
661
2880
C50.99
ICD-10 Finland
Breast, unspecified
3.1
50.5
297
853
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
27.1
49.7
71
23
1412
FHL
Laparoscopy and sterilization
0.4
49.2
220
4650
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.5
48.5
397
1399
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
48.4
5325
38915
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
47.8
3813
26541
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
2.6
46.8
368
1268
WX110
NOMESCO Finland
Local anesthesy
1.3
46.7
8935
70267
MA2JE
NOMESCO Finland
Ultrasound screening of fetal nuchal translucency
+∞
46.5
47
*
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
411.2
44.9
47
*
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
0.2
44.2
31
1702
F20.9
ICD-10 Finland
Schizophrenia, unspecified
0.2
43.9
32
1713
Z82.0
ICD-10 Finland
Family history of epilepsy and other diseases of the nervous system
29.8
43.8
61
18
PJA12
NOMESCO Finland
Sentinel node biopsy
1.9
43.5
688
3251
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
6.5
43.5
118
159
O80.8
ICD-10 Finland
Other single spontaneous delivery
74.7
43.2
51
6
KFD47
NOMESCO Finland
Closure of both spermatic cords with ligature
+∞
40.6
41
*
LCA20
NOMESCO Finland
Removal of foreign body from uterus
17.6
40.6
66
33
Z82.4
ICD-10 Finland
Family history of ischaemic heart disease and other diseases of the circulatory system
8.4
40.2
92
96
W90
ICPC
Uncompl labour/delivery livebirth
367.0
40.0
42
*
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.3
39.9
6337
48199
Q87.4
ICD-10 Finland
Marfan syndrome
19.1
39.9
63
29
Z31.0
ICD-10 Finland
Tuboplasty or vasoplasty after previous sterilization
+∞
39.6
40
*
O99.80
ICD-10 Finland
The fear of childbirth
358.1
39.0
41
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.3
38.5
2985
20560
KFH30
NOMESCO Finland
Vasovasostomy
96.6
38.4
44
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.4
37.2
2097
13690
N05AH02
ATC
clozapine; systemic
0.2
36.7
40
1668
H02AB02
ATC
dexamethasone; systemic
1.6
35.7
949
5261
103
Kela drug reimbursment
Diabetes, insulin-treated
0.7
35.6
1621
18977
N05AH03
ATC
olanzapine; systemic
0.5
35.4
290
4988
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
3.0
34.8
212
626
O21.9
ICD-10 Finland
Vomiting of pregnancy, unspecified
70.3
33.7
40
5
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
2.0
33.6
444
1961
M01AE01
ATC
ibuprofen; systemic, rectal
1.3
33.3
12170
101282
OAA12
SPAT
NA
+∞
32.7
33
*
215
Kela drug reimbursment
Diabetes, non-insulin-treated
0.7
32.5
1592
18461
Z84.8
ICD-10 Finland
Family history of other specified conditions
11.6
32.3
62
47
W84
ICPC
Pregnancy high risk
45.0
32.3
41
8
R2110
NOMESCO Finland
Giving the first information
1.9
32.0
519
2474
O82.10
ICD-10 Finland
Delivery by emergency caesarean section
81.2
31.8
37
*
A04AA02
ATC
granisetron; systemic, transdermal
1.8
31.7
588
2934
J01FA10
ATC
azithromycin; systemic
1.2
31.5
7175
56255
O82.0
ICD-10 Finland
Delivery by elective caesarean section
31.5
31.5
43
12
Z80.9
ICD-10 Finland
Family history of malignant neoplasm, unspecified
65.0
30.9
37
5
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.5
30.6
1259
7715
P72
ICPC
Schizophrenia
0.2
30.4
34
1397
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
3.5
30.3
149
378
HAB40
NOMESCO Finland
Wedge excision of mammary gland
1.9
30.1
450
2083
A10BA02
ATC
metformin; oral
0.7
29.9
1563
17972
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
0.2
29.8
23
1183
O48
ICD-10 Finland
Prolonged pregnancy
274.2
29.2
31
*
Z38.3
ICD-10 Finland
Twin, born in hospital
+∞
28.7
29
*
A03FA01
ATC
metoclopramide; systemic, rectal
1.4
28.3
1741
11495
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
3.1
28.1
162
463
N05AX08
ATC
risperidone; systemic
0.5
28.1
294
4708
O81.4
ICD-10 Finland
Vacuum extractor delivery
136.0
28.0
31
*
M03BX02
ATC
tizanidine; oral
1.2
28.0
7584
60208
Z35.9
ICD-10 Finland
Supervision of high-risk pregnancy, unspecified
+∞
27.7
28
*
XLA10
NOMESCO Finland
NA
2.2
27.3
292
1179
MA2XE
NOMESCO Finland
Other obstetric ultrasound examination
57.8
27.2
33
5
R01AD09
ATC
mometasone; nasal
1.2
26.8
4963
37831
F29
ICD-10 Finland
Unspecified nonorganic psychosis
0.5
26.3
168
3128
SPAT1189
SPAT
Other ultrasound examination during pregnancy
27.1
26.2
37
12
W85
ICPC
Gestational diabetes
68.1
26.1
31
*
MAC10
NOMESCO Finland
Antepartum dilatation of cervical canal
+∞
25.7
26
*
L03AA13
ATC
pegfilgrastim; parenteral
2.0
25.4
331
1456
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
25.2
8268
66535
SPAT1373
SPAT
Combined screening in early pregnancy
65.9
25.2
30
*
LGA20
NOMESCO Finland
Sterilisation by constriction of Fallopian tubes
122.8
25.2
28
*
Z32.0
ICD-10 Finland
Pregnancy, not (yet) confirmed
29.8
24.7
34
10
O13
ICD-10 Finland
Gestational [pregnancy-induced] hypertension
45.3
24.6
31
6
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
2.8
24.3
157
486
Z34
ICD-10 Finland
Supervision of normal pregnancy
63.7
24.3
29
*
SPAT1195
SPAT
Antenatal classes
2.3
24.1
232
895
Z39.1
ICD-10 Finland
Care and examination of lactating mother
+∞
23.7
24
*
W15
ICPC
Infertility/subfertility female
7.8
23.7
56
63
J01CA04
ATC
amoxicillin; systemic
1.2
23.6
10350
85361
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
3.0
23.4
139
405
Z83.4
ICD-10 Finland
Family history of other endocrine, nutritional and metabolic diseases
18.0
23.3
37
18
MAE00
NOMESCO Finland
Outlet vacuum delivery
79.0
23.2
27
*
OAA10
SPAT
NA
9.4
23.1
49
46
M01AH05
ATC
etoricoxib; oral
1.2
22.9
7084
56452
Z82.6
ICD-10 Finland
Family history of arthritis and other diseases of the musculoskeletal system and connective tissue
30.2
22.6
31
9
OAB43
SPAT
NA
1.3
22.6
1884
12997
Z30.9
ICD-10 Finland
Contraceptive management, unspecified
9.0
22.6
49
48
KFD43
NOMESCO Finland
Unilateral vasectomy or ligature of vas deferens
49.1
22.6
28
5
C50
ICD-10 Finland
Malignant neoplasm of breast
2.5
22.4
183
650
J01DB01
ATC
cefalexin; oral
1.2
22.2
10399
85970
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.2
22.1
4171
31687
O68.0
ICD-10 Finland
Labour and delivery complicated by fetal heart rate anomaly
40.9
21.8
28
6
O35.1
ICD-10 Finland
Maternal care for (suspected) chromosomal abnormality in fetus
47.3
21.6
27
5
Z35.7
ICD-10 Finland
Supervision of high-risk pregnancy due to social problems
201.6
21.4
23
*
WX402
NOMESCO Finland
General anaesthesia
1.3
21.2
1748
12030
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
21.1
7133
57107
TPH04
NOMESCO Finland
Cathetrisation of vein
1.3
20.9
2002
14064
N02BE01
ATC
paracetamol; systemic, rectal
1.2
20.9
10220
84514
O03.9
ICD-10 Finland
Spontaneous abortion, Complete or unspecified, without complication
8.6
20.8
46
47
N97.9
ICD-10 Finland
Female infertility, unspecified
7.7
20.7
49
56
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
2.2
20.6
210
834
O34.2
ICD-10 Finland
Maternal care due to uterine scar from previous surgery
20.9
20.5
31
13
L01BC06
ATC
capecitabine; oral
1.9
20.5
308
1434
G60.0
ICD-10 Finland
Hereditary motor and sensory neuropathy
8.1
20.5
47
51
W92
ICPC
Compl labour/ delivery livebirth
192.9
20.5
22
*
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
2.7
20.3
146
484
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
8.2
20.3
46
49
U07.2
ICD-10 Finland
COVID-19, virus not identified
1.3
20.2
1968
13851
F83
ICD-10 Finland
Mixed specific developmental disorders
3.2
20.2
109
300
T90
ICPC
Diabetes non-insulin dependent
0.8
20.2
1370
15270
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
0.8
20.2
1633
17808
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
0.6
20.0
418
5664
K03.64
ICD-10 Finland
Dental calculus supragingival
1.2
20.0
3122
23220
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
19.5
6068
48111
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
1.7
19.3
419
2195
J01MA02
ATC
ciprofloxacin; systemic
1.2
19.2
3772
28685
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.2
19.1
5171
40484
L02BG03
ATC
anastrozole; oral
2.4
19.0
166
613
Z82.7
ICD-10 Finland
Family history of congenital malformations, deformations and chromosomal abnormalities
7.3
18.9
46
55
WX720
NOMESCO Finland
Own respiration
1.7
18.7
365
1856
O36.5
ICD-10 Finland
Maternal care for poor fetal growth
50.4
18.7
23
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
2.3
18.6
168
631
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
2.8
18.6
126
401
R06AX27
ATC
desloratadine; oral
1.2
18.6
2847
21105
WX702
NOMESCO Finland
Supraglottic ventilation device
1.6
18.3
525
2967
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
0.8
18.3
1240
13833
N05AA02
ATC
levomepromazine; systemic
0.5
18.2
169
2795
KMAK
NOMESCO Finland
NA
1.2
18.2
6008
47773
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.5
18.1
566
3263
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
0.1
17.8
*
501
WX002
NOMESCO Finland
Sedation and analgesia
1.3
17.8
1790
12633
O47.9
ICD-10 Finland
False labour, unspecified
+∞
17.8
18
*
M01AB05
ATC
diclofenac; systemic, rectal
1.2
17.7
8013
65275
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
0.2
17.7
13
686
O20.9
ICD-10 Finland
Haemorrhage in early pregnancy, unspecified
61.5
17.6
21
*
O47.1
ICD-10 Finland
False labour at or after 37 completed weeks of gestation
61.5
17.6
21
*
SAA03
NOMESCO Finland
Extended examination of mouth
1.2
17.3
4639
36201
R06AE07
ATC
cetirizine; oral
1.2
17.3
4697
36695
N04AA02
ATC
biperiden; systemic
0.3
17.3
44
1171
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.6
17.3
412
2219
R51.80
ICD-10 Finland
Headache
1.3
17.2
1341
9146
F20.0
ICD-10 Finland
Paranoid schizophrenia
0.1
17.2
5
510
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
2.1
17.0
192
801
WX704
NOMESCO Finland
Intubation
1.5
16.9
676
4112
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.3
16.9
1768
12540
MBC30
NOMESCO Finland
Repair of partial rupture of perineum
+∞
16.8
17
*
Z35.6
ICD-10 Finland
Supervision of very young primigravida
+∞
16.8
17
*
OAB48
SPAT
NA
1.4
16.8
980
6394
JN4BD
NOMESCO Finland
Extensive body CT
1.4
16.7
946
6137
O32.1
ICD-10 Finland
Maternal care for breech presentation
58.3
16.7
20
*
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
4.7
16.7
57
106
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
12.5
16.6
30
21
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
157.7
16.6
18
*
O36.6
ICD-10 Finland
Maternal care for excessive fetal growth
157.7
16.6
18
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
2.4
16.4
143
529
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
1.9
16.3
231
1055
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.6
16.3
433
2400
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
2.2
16.2
169
681
W29
ICPC
Pregnancy symptom/complaint other
36.8
16.2
21
5
LGA10
NOMESCO Finland
Sterilisation by destruction or division of Fallopian tubes
36.8
16.2
21
5
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
2.6
16.1
123
424
L02BG06
ATC
exemestane; oral
2.6
16.0
115
383
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
0.5
16.0
105
1932
J01FA09
ATC
clarithromycin; systemic
1.2
15.9
3365
25686
O99.0
ICD-10 Finland
Anaemia complicating pregnancy, childbirth and the puerperium
+∞
15.8
16
*
O70.1
ICD-10 Finland
Second degree perineal laceration during delivery
+∞
15.8
16
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.3
15.8
1537
10796
R83
ICPC
Respiratory infection other
1.2
15.7
2624
19577
O26.82
ICD-10 Finland
Exhaustion and fatigue pregnancy-related
78.9
15.6
18
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
1.8
15.4
251
1205
J01DA01
ATC
[U] cefalexin; systemic
1.2
15.2
6947
56324
G71.11
ICD-10 Finland
Dystrophia myotonica [Steinert]
17.5
15.2
24
12
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
2.6
15.2
113
384
K02.1
ICD-10 Finland
Caries of dentine
1.2
15.1
7159
58189
188
Kela drug reimbursment
Psychosis requiring demanding treatment
0.2
15.1
18
707
F20
ICD-10 Finland
Schizophrenia
0.1
15.1
6
483
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
3.3
15.0
75
197
Q95.0
ICD-10 Finland
Balanced translocation and insertion in normal individual
41.6
15.0
19
*
R62.0
ICD-10 Finland
Delayed milestone
3.1
15.0
81
226
N05AX12
ATC
aripiprazole; systemic
0.6
14.9
193
2919
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.2
14.9
4817
38045
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
2.2
14.9
147
578
N05AX13
ATC
paliperidone; systemic
0.1
14.8
*
407
MAA00
NOMESCO Finland
Amniocentesis
+∞
14.8
15
*
O36.8
ICD-10 Finland
Maternal care for other specified fetal problems
+∞
14.8
15
*
TKF00
NOMESCO Finland
Needle biopsy of testis
14.6
14.8
25
15
C10AA01
ATC
simvastatin; oral
0.8
14.8
2915
29185
F20.04
ICD-10 Finland
Paranoid schizophrenia with partial recurrence
0.1
14.8
9
535
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
2.2
14.8
156
632
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.6
14.7
264
3694
MAC40
NOMESCO Finland
Pharmacological induction or advancement of labor
140.2
14.6
16
*
X76
ICPC
Malignant neoplasm breast female
2.3
14.5
140
547
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
3.0
14.4
83
241
TQW20
NOMESCO Finland
Tatoe
2.9
14.4
89
271
WX302
NOMESCO Finland
Thoracal epidural anesthesy
1.5
14.4
449
2589
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.4
14.4
722
4590
8221
FHL
Sterilization of the laparotomy pathway
0.4
14.4
80
1556
H35.5
ICD-10 Finland
Hereditary retinal dystrophy
4.0
14.3
57
124
SPAT1399
SPAT
Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.
2.0
14.3
181
794
N05AF05
ATC
zuclopenthixol; systemic
0.2
14.3
16
650
A04AD12
ATC
aprepitant; systemic
2.0
14.3
178
775
R4110
NOMESCO Finland
Physiotherapy
1.2
14.3
2634
19828
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
2.5
14.2
108
373
SAA01
NOMESCO Finland
Simple examination of mouth
1.1
14.1
8897
73632
O02.1
ICD-10 Finland
Missed abortion
6.2
14.1
38
54
N97.4
ICD-10 Finland
Female infertility associated with male factors
15.5
14.0
23
13
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
8.2
13.9
31
33
O21
ICD-10 Finland
Excessive vomiting in pregnancy
49.7
13.9
17
*
ZXA00
NOMESCO Finland
Right side
1.2
13.9
2494
18718
R01AD12
ATC
fluticasone furoate; nasal
1.2
13.9
3045
23276
Z36.8
ICD-10 Finland
Other antenatal screening
+∞
13.9
14
*
O14.9
ICD-10 Finland
Pre-eclampsia, unspecified
+∞
13.9
14
*
E11
ICD-10 Finland
Type 2 diabetes mellitus
0.8
13.7
846
9566
Z35.0
ICD-10 Finland
Supervision of pregnancy with history of infertility
131.4
13.7
15
*
F20.3
ICD-10 Finland
Undifferentiated schizophrenia
0.1
13.7
*
381
8306
FHL
Hysterectomy (related to abortion 8516, prolapse correction 8436)
0.5
13.7
86
1603
A10AE04
ATC
insulin glargine; parenteral
0.7
13.6
524
6345
O42.9
ICD-10 Finland
Premature rupture of membranes, unspecified
31.6
13.5
18
5
I10
ICD-10 Finland
Essential (primary) hypertension
0.9
13.5
4542
43735
WX400
NOMESCO Finland
Inhalation anesthesy
1.5
13.4
397
2265
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.5
13.4
458
2699
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
1.6
13.3
329
1795
W05
ICPC
Pregnancy vomiting/nausea
37.2
13.2
17
*
N63
ICD-10 Finland
Unspecified lump in breast
1.6
13.2
308
1653
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.2
13.2
2067
15302
LCA13
NOMESCO Finland
Curettage of cervix and body of uterus
1.5
13.1
419
2436
N05AB03
ATC
perphenazine; systemic, rectal
0.5
13.1
140
2221
W79
ICPC
Unwanted pregnancy
8.2
13.0
29
31
Z82.8
ICD-10 Finland
Family history of other disabilities and chronic diseases leading to disablement, not elsewhere classified
46.7
13.0
16
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
1.7
13.0
284
1500
Q93.8
ICD-10 Finland
Other deletions from the autosomes
26.3
12.9
18
6
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.1
12.9
6409
52027
J01AA02
ATC
doxycycline; systemic
1.1
12.9
8917
74009
SPAT1308
SPAT
Sexual health counselling
1.4
12.9
527
3226
O35.8
ICD-10 Finland
Maternal care for other (suspected) fetal abnormality and damage
+∞
12.9
13
*
Z35.5
ICD-10 Finland
Supervision of elderly primigravida
+∞
12.9
13
*
Z31.3
ICD-10 Finland
Other assisted fertilization methods
+∞
12.9
13
*
Z31.9
ICD-10 Finland
Procreative management, unspecified
+∞
12.9
13
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
2.5
12.8
97
336
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
65.8
12.8
15
*
R01AD08
ATC
fluticasone; nasal
1.2
12.8
2874
21990
WX725
NOMESCO Finland
Noninvasive ventilation
1.5
12.6
409
2385
F10.25
ICD-10 Finland
Alcohol dependence continuous use
0.4
12.5
67
1321
LCH11
NOMESCO Finland
Pharmacologic abortion
5.3
12.5
38
63
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.2
12.5
3299
25567
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
1.4
12.5
661
4243
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
2.6
12.5
93
319
2180A
ICD-9 Finland
Uterine leiomyoma, Submucous leiomyoma of uterus
0.6
12.4
160
2418
H01AC01
ATC
somatropin; parenteral
3.2
12.4
65
179
Y10
ICPC
Infertility/subfertility male
7.9
12.4
28
31
1744A
ICD-9 Finland
Malignant neoplasm of female breast, Upper-outer quadrant
3.9
12.3
51
116
O23.5
ICD-10 Finland
Infections of the genital tract in pregnancy
35.0
12.3
16
*
128
Kela drug reimbursment
Cancers of female genital organs
2.2
12.3
121
478
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.4
12.3
719
4694
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
1.3
12.2
885
5970
G71.08
ICD-10 Finland
Other muscular dystrophy
6.0
12.1
33
48
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
2.5
12.1
97
346
O72.1
ICD-10 Finland
Other immediate postpartum haemorrhage
43.8
12.1
15
*
LGA00
NOMESCO Finland
Sterilisation by ligature of Fallopian tubes
43.8
12.1
15
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.3
12.0
1220
8606
Q99.8
ICD-10 Finland
Other specified chromosome abnormalities
13.1
12.0
21
14
A10BH01
ATC
sitagliptin; oral
0.7
12.0
402
4981
I71.2
ICD-10 Finland
Thoracic aortic aneurysm, without mention of rupture
1.7
11.9
222
1119
Z80.5
ICD-10 Finland
Family history of malignant neoplasm of urinary tract
61.4
11.9
14
*
N05AF03
ATC
chlorprothixene; systemic
0.5
11.8
107
1776
G03AC03
ATC
levonorgestrel; systemic
1.4
11.8
562
3545
MBC10
NOMESCO Finland
Repair of obstetric laceration of vagina
113.9
11.8
13
*
R06.5
ICD-10 Finland
Mouth breathing
1.3
11.7
988
6805
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.2
11.7
3238
25168
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
0.7
11.7
354
4459
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
1.8
11.6
190
920
W01
ICPC
Question of pregnancy
7.0
11.5
28
35
OAB95
SPAT
NA
1.4
11.5
560
3544
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
1.7
11.5
251
1329
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.3
11.4
859
5824
TPH07
NOMESCO Finland
Cathetrisation of artery
1.3
11.4
838
5668
SPAT1381
SPAT
Extensive health check-up at 4 months of age
3.3
11.3
57
153
MBA03
NOMESCO Finland
Curettage of uterus after delivery or abortion
4.6
11.2
38
72
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
1.9
11.2
168
789
PD5CG
NOMESCO Finland
Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet
3.7
11.1
48
114
JN4AD
NOMESCO Finland
Body CT examination
1.4
11.1
594
3820
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
1.6
11.1
282
1554
WYA40
NOMESCO Finland
Assessment of oral health and treatment needs for family expecting first child
2.3
11.1
103
398
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
0.7
11.1
330
4167
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.2
11.1
2015
15115
N02AJ06
ATC
codeine and paracetamol; systemic
1.1
11.1
4085
32407
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
7.8
11.0
25
28
Q85.1
ICD-10 Finland
Tuberous sclerosis
11.7
10.9
20
15
FM1QE
NOMESCO Finland
Extensive ultrasound of fetal heart
+∞
10.9
11
*
Z81.0
ICD-10 Finland
Family history of mental retardation
+∞
10.9
11
*
D82
ICPC
Teeth/gum disease
1.1
10.9
3832
30292
A98
ICPC
Health maint/preventive medicine
1.3
10.9
13432
115509
LCH03
NOMESCO Finland
Evacuation of products of conception and curettage of uterus
8.1
10.8
24
26
SPAT1200
SPAT
Guidance for breast-feeding and breast care
7.6
10.8
25
29
O72.0
ICD-10 Finland
Third-stage haemorrhage
105.1
10.8
12
*
WX322
NOMESCO Finland
Combined spinal-epidural analgesia in obstetrics
105.1
10.8
12
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
3.0
10.7
62
183
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
1.3
10.7
654
4300
XA800
NOMESCO Finland
Neuropsychological investigation
1.4
10.7
434
2659
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.4
10.7
459
2841
Z01.2
ICD-10 Finland
Dental examination
1.1
10.6
4664
37400
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
2.2
10.6
107
429
Q98.0
ICD-10 Finland
Klinefelter syndrome karyotype 47,XXY
7.3
10.6
25
30
A04AA01
ATC
ondansetron; systemic, rectal
1.4
10.6
516
3267
N05AA01
ATC
chlorpromazine; systemic, rectal
0.4
10.6
38
865
I71.09
ICD-10 Finland
Aortic dissection [regardless of location]
3.6
10.6
47
115
F10.20
ICD-10 Finland
Alcohol dependence currently independent
0.5
10.6
91
1533
WX230
NOMESCO Finland
Plexus blockade of nervus pudendus
30.7
10.5
14
*
F10.24
ICD-10 Finland
Alcohol depence active use
0.4
10.5
53
1062
VALMI
NOMESCO Finland
NA
1.2
10.5
2727
21077
R74
ICPC
Upper respiratory infection acute
1.2
10.4
2855
22147
L03AA02
ATC
filgrastim; parenteral
1.7
10.4
218
1143
B02AA02
ATC
tranexamic acid; systemic
1.3
10.3
799
5446
R21
ICPC
Throat symptom/complaint
1.2
10.2
1898
14253
F20.34
ICD-10 Finland
Undifferentiated schizophrenia with partial recurrence
0.1
10.2
5
343
I71.00
ICD-10 Finland
Dissecting aneurysm of aorta (ruptured) [any part]
3.4
10.1
47
120
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
2.0
10.0
131
588
B18.2
ICD-10 Finland
Chronic viral hepatitis C
0.4
10.0
44
925
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
0.6
10.0
116
1799
S01GX01
ATC
cromoglicic acid; ophthalmic
1.2
10.0
1866
14020
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
3.5
10.0
46
116
LCA22
NOMESCO Finland
Hysteroscopic removal of foreign body
24.5
10.0
14
5
Z35.2
ICD-10 Finland
Supervision of pregnancy with other poor reproductive or obstetric history
+∞
9.9
10
*
O21.0
ICD-10 Finland
Mild hyperemesis gravidarum
+∞
9.9
10
*
O64.0
ICD-10 Finland
Obstructed labour due to incomplete rotation of fetal head
+∞
9.9
10
*
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
2.8
9.9
62
194
O02.0
ICD-10 Finland
Blighted ovum and nonhydatidiform mole
5.6
9.8
28
44
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1.5
9.8
356
2133
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
3.5
9.8
45
114
N05AD01
ATC
haloperidol; systemic
0.5
9.7
87
1447
Z30
ICD-10 Finland
Contraceptive management
3.3
9.7
48
128
8500/3-C50.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of central portion of breast
3.6
9.7
42
101
J34.2
ICD-10 Finland
Deviated nasal septum
1.3
9.7
632
4203
R50.9
ICD-10 Finland
Fever, unspecified
1.2
9.7
1280
9302
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.2
9.6
2498
19286
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
1.4
9.6
428
2667
OAA65
SPAT
NA
1.3
9.6
852
5908
Z01.8
ICD-10 Finland
Other specified special examinations
1.2
9.6
1989
15079
-1
NOMESCO Finland
NA
1.1
9.6
3843
30591
A04AA55
ATC
palonosetron, combinations; systemic
1.7
9.5
203
1068
I86.1
ICD-10 Finland
Scrotal varices
1.9
9.5
137
638
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.3
9.5
569
3733
M03BC01
ATC
orphenadrine (citrate); systemic
1.2
9.5
2364
18194
J02AC01
ATC
fluconazole; systemic
1.2
9.4
2855
22295
M01AE02
ATC
naproxen; oral, rectal
1.1
9.4
6382
52424
XMA22
NOMESCO Finland
General examination of pregnant woman
35.0
9.3
12
*
Y89.9
ICD-10 Finland
Sequelae of unspecified external cause
2.2
9.3
88
344
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
3.1
9.3
50
143
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
0.5
9.2
80
1340
C07AB07
ATC
bisoprolol; oral
0.9
9.2
3369
32456
Z40.0
ICD-10 Finland
Prophylactic surgery for risk-factors related to malignant neoplasms
22.8
9.1
13
5
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
2.9
9.1
54
164
W14
ICPC
Contraception female other
1.8
9.1
140
668
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.1
9.1
5528
45093
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
0.4
9.1
27
667
FM2CE
NOMESCO Finland
NA
2.3
9.1
81
309
OAB30
SPAT
NA
48.2
9.1
11
*
TQX22
NOMESCO Finland
Removal of subcutaneous medicament implant
48.2
9.1
11
*
D44.8
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement
6.9
9.1
22
28
G71.3
ICD-10 Finland
Mitochondrial myopathy, not elsewhere classified
8.0
9.1
20
22
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
2.3
9.0
78
295
O75.6
ICD-10 Finland
Delayed delivery after spontaneous or unspecified rupture of membranes
+∞
8.9
9
*
O28.8
ICD-10 Finland
Other abnormal findings on antenatal screening of mother
87.6
8.9
10
*
O41.0
ICD-10 Finland
Oligohydramnios
87.6
8.9
10
*
O26.88
ICD-10 Finland
Other specified pregnancy-related conditions
87.6
8.9
10
*
I71.9
ICD-10 Finland
Aortic aneurysm of unspecified site, without mention of rupture
2.0
8.9
104
447
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
3.3
8.9
43
114
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
3.3
8.9
43
114
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.2
8.9
1101
7949
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
2.8
8.8
56
177
LCH00
NOMESCO Finland
Vacuum aspiration of products of conception from uterus
7.1
8.8
21
26
C08CA01
ATC
amlodipine; oral
0.9
8.8
2467
24192
O63.1
ICD-10 Finland
Prolonged second stage (of labour)
26.3
8.8
12
*
I78.0
ICD-10 Finland
Hereditary haemorrhagic telangiectasia
5.0
8.8
27
47
W12
ICPC
Contraception intrauterine
1.9
8.8
131
620
UJF32
NOMESCO Finland
Coloscopy
1.2
8.8
2185
16812
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
3.5
8.7
39
97
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
0.2
8.7
7
344
J31.0
ICD-10 Finland
Chronic rhinitis
1.3
8.7
669
4554
Z30.4
ICD-10 Finland
Surveillance of contraceptive drugs
1.7
8.7
164
836
N01
ICPC
Headache
1.2
8.7
959
6834
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.4
8.7
470
3036
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
3.2
8.7
44
121
M03BC51
ATC
orphenadrine, combinations; systemic
1.1
8.7
2757
21591
Y14
ICPC
Family planning male other
8.8
8.6
18
18
O03.4
ICD-10 Finland
Spontaneous abortion, Incomplete, without complication
7.9
8.6
19
21
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
3.8
8.6
35
81
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
2.1
8.5
90
371
D01BA02
ATC
terbinafine; oral; topical
1.1
8.5
2611
20397
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
1.5
8.5
283
1671
O91.2
ICD-10 Finland
Nonpurulent mastitis associated with childbirth
32.1
8.4
11
*
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.2
8.4
1841
14014
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
2.7
8.4
57
188
XX3DW
NOMESCO Finland
Time consuming IT work
1.3
8.3
787
5507
E29.1
ICD-10 Finland
Testicular hypofunction
1.7
8.3
177
934
O60
ICD-10 Finland
Preterm labour and delivery
16.3
8.3
13
7
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
0.1
8.3
5
296
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
0.8
8.3
440
5071
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
3.1
8.2
43
121
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
3.7
8.2
35
84
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.2
8.2
1453
10859
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
0.4
8.2
44
860
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.3
8.2
699
4830
S83.2
ICD-10 Finland
Tear of meniscus, current
1.3
8.2
811
5710
O24.9
ICD-10 Finland
Diabetes mellitus in pregnancy, unspecified
43.8
8.2
10
*
F22.0
ICD-10 Finland
Delusional disorder
0.4
8.1
40
807
B01AB05
ATC
enoxaparin; parenteral
1.1
8.1
2489
19431
R03DC03
ATC
montelukast; oral
1.2
8.1
1387
10340
X21
ICPC
Breast sympt/compl female other
2.0
8.1
98
429
NK6AN
NOMESCO Finland
Total body bone isotope imaging
1.7
8.1
170
897
X59
ICD-10 Finland
Exposure to unspecified factor
1.2
8.1
2023
15563
N48.4
ICD-10 Finland
Impotence of organic origin
1.5
8.0
228
1298
H66.9
ICD-10 Finland
Otitis media, unspecified
1.3
8.0
564
3794
G11.8
ICD-10 Finland
Other hereditary ataxias
9.3
8.0
16
15
EB1MA
NOMESCO Finland
Cephalometry with X-ray
1.4
8.0
336
2078
G03GA05
ATC
follitropin alfa; parenteral
5.7
8.0
22
34
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
1.2
7.9
1256
9293
F82
ICD-10 Finland
Specific developmental disorder of motor function
2.5
7.9
58
200
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
2.2
7.9
74
291
XMA00
NOMESCO Finland
NA
24.1
7.9
11
*
Z35
ICD-10 Finland
Supervision of high-risk pregnancy
+∞
7.9
8
*
Z39.0
ICD-10 Finland
Care and examination immediately after delivery
+∞
7.9
8
*
O36.9
ICD-10 Finland
Maternal care for fetal problem, unspecified
+∞
7.9
8
*
O46.9
ICD-10 Finland
Antepartum haemorrhage, unspecified
+∞
7.9
8
*
W99
ICPC
Disorder of pregn/delivery other
+∞
7.9
8
*
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.1
7.9
6505
53799
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.2
7.9
927
6652
ZX120
NOMESCO Finland
Intravenous
1.3
7.9
759
5325
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.4
7.9
428
2770
D19
ICPC
Teeth/gum symptom/complaint
1.1
7.8
2695
21203
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
3.4
7.8
36
93
F21
ICD-10 Finland
Schizotypal disorder
0.3
7.8
13
418
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
2.0
7.8
96
425
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
0.4
7.7
37
754
K02.0
ICD-10 Finland
Caries limited to enamel
1.2
7.7
1393
10429
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
0.6
7.7
92
1412
Q85.0
ICD-10 Finland
Neurofibromatosis (nonmalignant)
7.8
7.7
17
19
HAB99
NOMESCO Finland
Other partial excision of mammary gland
1.7
7.7
149
767
J01DA06
ATC
[U] cefuroxime; systemic
1.2
7.7
1307
9733
WX1PA
NOMESCO Finland
Total body mineral density measurement with Dual energy X-ray absorptiometry (DXA)
4.9
7.7
24
43
FCA75
NOMESCO Finland
Valve-sparing repair of aortic root (David, Yacoub)
4.9
7.7
24
43
J05AB11
ATC
valaciclovir; oral
1.2
7.7
1009
7331
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.3
7.7
694
4832
N02AX02
ATC
tramadol; systemic, rectal
1.1
7.6
4256
34466
F20.10
ICD-10 Finland
Raise schizophrenia continuously
0.1
7.6
*
263
Z20.8
ICD-10 Finland
Contact with and exposure to other communicable diseases
1.2
7.6
810
5754
HAE99
NOMESCO Finland
Other reconstruction of breast
2.8
7.6
48
152
MBA40
NOMESCO Finland
Pharmacological evacuation of uterus after abortion
29.2
7.6
10
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
2.4
7.6
63
235
SPAT1316
SPAT
Extensive health check-up of children and adolescents
1.2
7.5
833
5941
L02BA03
ATC
fulvestrant; parenteral
3.1
7.5
39
110
8305
FHL
Supravaginal amputation or resection
0.4
7.5
36
730
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
2.8
7.5
46
145
X02
ICPC
Menstrual pain
1.6
7.5
197
1103
R03AC02
ATC
salbutamol; inhalant
1.1
7.5
5519
45347
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.1
7.5
2602
20484
G03GA01
ATC
chorionic gonadotrophin; parenteral
2.4
7.4
62
231
G71.18
ICD-10 Finland
Other myotonic disease
5.8
7.4
20
30
9706
FHL
Ablation mammae, includes axillary exploration
5.8
7.4
20
30
DJD20
NOMESCO Finland
Plastic repair of septum of nose
1.3
7.4
432
2826
C50.2
ICD-10 Finland
Malignant neoplasm: Upper-inner quadrant of breast
4.2
7.4
27
57
TQX20
NOMESCO Finland
Implantation of subcutaneous medicament implant
4.7
7.4
24
45
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
0.4
7.4
26
593
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
1.8
7.4
117
567
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.3
7.3
611
4213
HAC25
NOMESCO Finland
Radical mastectomy
3.2
7.3
36
98
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
0.4
7.3
24
562
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
3.5
7.3
32
80
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
0.5
7.3
48
872
N05CD07
ATC
temazepam; oral
0.8
7.2
601
6555
XF404
NOMESCO Finland
Ambulatory ECG
1.3
7.2
715
5033
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.4
7.2
381
2456
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
1.7
7.2
143
744
C09AA05
ATC
ramipril; oral
0.9
7.2
1496
15000
GD1AA
SPAT
NA
1.3
7.2
680
4761
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.2
7.2
1218
9068
WX234
NOMESCO Finland
Paracervical blockade
3.3
7.2
34
90
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
0.4
7.1
24
560
205
Kela drug reimbursment
Chronic hypertension
0.9
7.1
1534
15346
N97.0
ICD-10 Finland
Female infertility associated with anovulation
9.4
7.1
14
13
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
1.4
7.1
391
2539
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
2.8
7.1
45
143
M22.4
ICD-10 Finland
Chondromalacia patellae
1.5
7.1
258
1553
1CD02
NOMESCO Finland
NA
2.4
7.1
59
220
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
1.3
7.1
482
3233
K05.32
ICD-10 Finland
Periodontitis NOS
1.3
7.1
538
3664
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
2.3
7.0
59
221
17402
ICD-8 Finland
Malignant neoplasm of breast, Glandulae
5.7
7.0
19
29
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
0.4
7.0
34
687
ZX080
NOMESCO Finland
Image guided radiotherapy
1.7
7.0
132
675
6262A
ICD-9 Finland
Disorders of menstruation and other abnormal bleeding from female genital tract, Excessive or frequent menstruation[HYPERMENORRHOEA]
0.5
7.0
67
1089
F90.0
ICD-10 Finland
Disturbance of activity and attention
1.4
7.0
276
1689
5702
FHL
Local lymph node removal (eg armpit, groin)
3.7
7.0
29
69
N94.4
ICD-10 Finland
Primary dysmenorrhoea
2.1
7.0
79
338
O26.7
ICD-10 Finland
Subluxation of symphysis (pubis) in pregnancy, childbirth and the puerperium
70.1
7.0
8
*
W13
ICPC
Sterilization female
70.1
7.0
8
*
O30.0
ICD-10 Finland
Twin pregnancy
70.1
7.0
8
*
G71.9
ICD-10 Finland
Primary disorder of muscle, unspecified
4.4
7.0
24
48
P85
ICPC
Mental retardation
3.4
7.0
32
83
D35.59
ICD-10 Finland
Other paragangliom
10.4
6.9
13
11
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
2.8
6.9
42
132
MAC02
NOMESCO Finland
Rupture of aminiotic membrane for advancement of labor
+∞
6.9
7
*
TMA00
NOMESCO Finland
Episiotomy
+∞
6.9
7
*
MAC01
NOMESCO Finland
Rupture of aminiotic membrane for induction of labor
+∞
6.9
7
*
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
0.6
6.9
83
1268
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
0.6
6.9
85
1288
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.2
6.9
881
6383
C50.50
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication
3.6
6.9
29
70
LCA10
NOMESCO Finland
Curettage of body of uterus
1.8
6.9
113
555
I97.2
ICD-10 Finland
Postmastectomy lymphoedema syndrome
3.0
6.9
37
108
N05AC02
ATC
thioridazine; oral
0.5
6.9
68
1093
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
2.6
6.9
46
154
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
1.4
6.8
359
2312
PD5CM
NOMESCO Finland
Extensive MRI examination of thoracal and abdominal aorta with 3 Tesla magnet
7.7
6.8
15
17
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
1.4
6.8
314
1981
A79
ICPC
Malignancy NOS
2.0
6.8
86
385
N05AE03
ATC
sertindole; oral
0.0
6.8
*
177
G72.9
ICD-10 Finland
Myopathy, unspecified
2.1
6.8
68
278
KFD16
NOMESCO Finland
Partial excision of epididymis
3.7
6.8
28
67
A02BC05
ATC
esomeprazole; systemic
1.1
6.7
3925
31817
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
2.5
6.7
51
182
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
1.2
6.7
1051
7772
O26.6
ICD-10 Finland
Liver disorders in pregnancy, childbirth and the puerperium
26.3
6.7
9
*
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
2.0
6.7
81
357
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
0.4
6.7
24
541
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.1
6.7
2483
19616
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
2.6
6.6
44
146
C57.0
ICD-10 Finland
Malignant neoplasm: Fallopian tube
3.6
6.6
28
68
186
Kela drug reimbursment
Growth retardation associated with renal failure (growth hormone)
3.6
6.6
28
68
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
3.0
6.6
35
101
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.2
6.6
1537
11747
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
2.4
6.6
51
184
G47.3
ICD-10 Finland
Sleep apnoea
1.1
6.6
2401
18936
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.3
6.6
654
4607
1511
Kela drug reimbursment
Olaparib
17.5
6.6
10
5
XX4AW
NOMESCO Finland
NA
2.8
6.6
40
126
A10AA02
ATC
NA
0.7
6.6
153
2012
LCA06
NOMESCO Finland
Biopsy of endometrium
1.3
6.6
509
3478
R03BB04
ATC
tiotropium bromide; inhalant
0.8
6.6
393
4452
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
0.5
6.5
48
843
B01AB10
ATC
tinzaparin; parenteral
1.3
6.5
479
3250
J02AC02
ATC
itraconazole; systemic
1.2
6.5
1482
11313
KFD96
NOMESCO Finland
Other excision or ligature of scrotal organs
6.0
6.5
17
25
M54.5
ICD-10 Finland
Low back pain
1.1
6.5
3190
25612
8507/3-C50.9
ICD-O-3
Invasive micropapillary carcinoma of breast of breast, NOS
10.5
6.5
12
10
XCD00
NOMESCO Finland
Clinical examination of eye in general anaesthesia
4.9
6.5
20
36
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
2.3
6.5
53
198
WX290
NOMESCO Finland
Other blockade of nerve
1.1
6.4
5289
43594
WX306
NOMESCO Finland
Lumbar epidural anesthesy
1.5
6.4
218
1294
C18.22
ICD-10 Finland
Malignant tumor of the colon ascending carcinoma of the adenoma
5.4
6.4
18
29
N05AH04
ATC
quetiapine; oral
0.9
6.4
1277
12849
Q78.00
ICD-10 Finland
Congenital osteogenesis imperfecta
6.9
6.4
15
19
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
1.8
6.4
95
451
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.3
6.4
574
3997
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.2
6.4
1010
7477
QBB00
NOMESCO Finland
Suture of skin of trunk
2.4
6.3
52
194
I50.9
ICD-10 Finland
Heart failure, unspecified
0.8
6.3
347
3978
O42.0
ICD-10 Finland
Premature rupture of membranes, onset of labour within 24 hours
35.0
6.3
8
*
O63.0
ICD-10 Finland
Prolonged first stage (of labour)
35.0
6.3
8
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
0.7
6.3
229
2789
C50.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of breast
4.3
6.3
22
45
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
1.4
6.3
237
1439
R4190
NOMESCO Finland
Nutritional therapy
1.4
6.3
319
2046
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
3.0
6.3
34
100
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
2.3
6.3
54
206
NGE35
NOMESCO Finland
Plastic repair of ligament of knee not using prosthetic material, anterior cruciate, arthroscopic
1.4
6.3
329
2123
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
1.3
6.3
395
2625
N05BA02
ATC
chlordiazepoxide; systemic
0.6
6.3
99
1411
G43.8
ICD-10 Finland
Other migraine
2.0
6.2
76
338
Q85.82
ICD-10 Finland
of Hipple-Lindau syndrome
19.7
6.2
9
*
N97.8
ICD-10 Finland
Female infertility of other origin
19.7
6.2
9
*
LAA01
NOMESCO Finland
Laparoscopic puncture of ovarian cyst
9.6
6.2
12
11
TPX10
NOMESCO Finland
Implantation of vascular injection port
1.4
6.2
234
1425
AJ1
HP
Reconstruction of the aortic base, eg composite graft, incl. valve saving operation
3.7
6.2
25
59
KFB01
NOMESCO Finland
Microscope-assisted testicular biopsy for assisted reproduction treatments
8.1
6.2
13
14
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
1.6
6.2
141
766
M79.6
ICD-10 Finland
Pain in limb
1.1
6.1
3263
26307
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
2.3
6.1
54
210
D09
ICPC
Nausea
1.4
6.1
341
2223
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.3
6.1
350
2291
WF003
NOMESCO Finland
Adjuvant radiotherapy
1.4
6.1
238
1458
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
0.8
6.1
315
3636
8461/3-C57.0
ICD-O-3
High grade serous carcinoma of fallopian tube
4.3
6.1
21
43
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
4.5
6.1
20
39
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
0.6
6.1
109
1511
602
Kela drug reimbursment
Children's severe malnutrition
2.3
6.0
50
188
G12.1
ICD-10 Finland
Other inherited spinal muscular atrophy
10.7
6.0
11
9
G11.4
ICD-10 Finland
Hereditary spastic paraplegia
10.7
6.0
11
9
DHB50
NOMESCO Finland
Turbinoplasty
1.4
6.0
260
1622
J01FA06
ATC
roxithromycin; oral
1.1
6.0
3850
31326
OAA80
SPAT
NA
1.2
6.0
712
5120
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3034274) Bile acid [Moles/volume] in Serum --fasting
810
909
6.17
307.65
2.3
2.5
umol/l
5.7
12.7
7.38
615
701
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
1602
625
18.21
307.65
1.4
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
464
187
17.04
307.65
1.5
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
1612
625
18.33
307.65
1.5
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
7910
25516
2.45
307.65
1.7
1.6
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
1610
625
18.31
307.65
1.5
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
1550
828
13.27
307.65
1.8
1.6
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
995
175
39.71
307.65
6.9
3.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
934
139
46.84
307.65
1.2
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
1605
998
11.41
307.65
1.6
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
1610
619
18.49
307.65
1.4
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
3299
1878
13.13
307.65
1.5
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
1288
515
17.60
307.65
1.5
1.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
8899
36065
1.92
307.65
2.0
2.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
1388
989
9.89
307.65
1.5
1.3
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
512
260
13.54
307.65
1.6
1.3
mmol/l
7.4
9.0
6.19
300
146
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
1756
691
18.14
307.65
1.5
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
1261
455
19.49
307.65
1.5
1.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
1264
461
19.29
307.65
1.5
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
2153
1348
11.52
307.65
1.4
1.3
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
996
175
39.75
307.65
3.5
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
5368
15186
2.67
307.65
1.7
1.8
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
456
493
6.34
229.50
1.0
1.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
2025
6562
2.16
199.34
2.6
2.2
u/l
8698.8
2852.1
10.56
933
1673
(3021879) Hepatitis B virus core Ab [Presence] in Serum
3743
15047
1.77
197.41
1.5
1.5
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
17879
101498
1.43
197.08
4.1
3.7
e6/l
669.3
1198.5
0.94
225
1331
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
23170
138062
1.47
196.72
3.4
3.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
13426
72391
1.44
196.26
4.1
3.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
9296
47293
1.46
180.99
1.7
1.3
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
162
42
26.26
175.48
1.3
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
5276
24211
1.57
165.14
1.6
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
1866
6296
2.07
164.80
1.5
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
3883
16635
1.66
160.49
1.8
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
19052
111862
1.37
151.50
4.0
3.8
—
—
—
0
0
(4038314)
201
139
9.85
141.77
1.2
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
5824
28228
1.48
138.59
1.5
1.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
299
362
5.64
135.46
2.2
4.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5718
28330
1.45
119.28
2.2
2.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
2091
8286
1.76
112.72
1.4
1.4
iu/l
27.4
28.5
0.71
1701
6937
(3023511) Choriogonadotropin [Units/volume] in Urine
1086
3541
2.12
104.04
1.4
1.3
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
164
144
7.75
98.10
3.2
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
3274
15073
1.52
96.53
1.9
2.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5177
26088
1.41
95.83
2.1
2.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
12876
74293
1.29
95.29
2.9
2.7
ug/l
102.9
121.2
11.24
12231
69948
(3002385) Erythrocyte distribution width [Ratio]
24895
156567
1.33
92.24
14.3
14.4
%
13.5
13.5
1.48
24477
153311
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
7588
40891
1.34
91.84
1.7
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
8529
46983
1.31
87.65
2.3
2.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
11588
66476
1.28
87.31
2.0
1.9
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
1217
4432
1.89
85.64
1.4
1.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
13902
82440
1.25
75.43
3.3
3.2
estimate
0.0
0.0
0.02
2594
14363
(3035350) Ketones [Presence] in Urine by Test strip
13737
81363
1.25
75.29
3.2
3.2
estimate
0.0
0.0
0.21
2556
14449
(3021601) Nitrite [Presence] in Urine by Test strip
13788
81729
1.25
74.90
4.5
4.4
estimate
0.0
0.0
0.86
2637
14984
(40761511) CBC panel - Blood by Automated count
29613
193131
1.42
67.58
10.7
10.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
634
1989
2.18
66.82
1.5
1.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
1213
4821
1.73
64.01
2.0
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
7093
39700
1.27
59.96
2.6
2.7
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
1522
6545
1.60
59.44
1.6
1.5
u/l
8.7
8.6
0.24
1185
5259
(3010813) Leukocytes [#/volume] in Blood
31663
209953
1.72
58.87
17.2
17.1
e9/l
6.5
6.6
0.60
31015
204480
(3026361) Erythrocytes [#/volume] in Blood
31656
209898
1.72
58.79
17.1
17.1
e12/l
4.6
4.6
52.01
31017
204432
(3035941) MCH [Entitic mass]
31649
209839
1.71
58.79
17.0
17.0
pg
30.1
30.2
6.07
31412
207394
(3024731) MCV [Entitic volume]
31651
209866
1.71
58.58
17.1
17.0
fl
90.1
90.2
9.08
31413
207416
(3000963) Hemoglobin [Mass/volume] in Blood
31665
209994
1.72
58.37
17.2
17.2
g/l
137.1
138.7
82.06
31426
207583
(3007461) Platelets [#/volume] in Blood
31615
209591
1.69
58.01
17.2
17.1
e9/l
256.8
258.7
6.13
31017
204575
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
28158
182895
1.31
57.38
11.8
11.7
mg/l
20.9
21.8
5.12
21987
139784
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
601
1967
2.09
56.98
1.4
1.4
ug/l
4.9
4.3
0.43
544
1688
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
5307
44182
0.78
55.62
3.5
3.5
ug/l
1.6
1.9
2.93
4966
40679
(3009542) Hematocrit [Volume Fraction] of Blood
27484
178163
1.29
54.56
12.9
12.4
%
40.7
40.9
5.07
22760
142199
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
4563
24413
1.31
54.07
1.5
1.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
1651
7416
1.54
53.31
1.6
1.7
mu/l
280.1
329.7
8.52
1513
6714
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
63
34
12.58
51.29
1.1
1.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
6401
36029
1.25
50.13
2.2
2.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
2581
12910
1.39
47.37
1.8
2.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
204
440
3.16
45.18
1.2
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
182
375
3.30
43.33
1.2
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
7961
46447
1.21
43.32
2.8
2.8
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
398
1239
2.19
42.89
1.4
1.2
mmol/l
9.9
12.1
2.92
63
468
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
10702
64239
1.19
42.76
3.2
3.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
25468
165106
1.21
38.71
4.6
4.4
mu/l
2.1
2.1
0.13
24182
154272
(3018095) Leukocytes [#/volume] in Urine
9190
54800
1.19
38.55
3.6
3.5
e6/l
67.8
72.2
0.31
6212
38035
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
21764
139206
1.18
38.33
4.0
3.8
pmol/l
14.5
14.6
16.69
20550
128134
(3005082) Progesterone [Moles/volume] in Serum or Plasma
237
616
2.62
37.86
1.4
1.4
nmol/l
31.3
29.9
0.26
215
550
(3003338) MCHC [Mass/volume]
25707
166992
1.20
36.88
14.8
14.5
g/l
333.6
333.6
0.20
25557
165868
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
628
2438
1.76
35.99
4.2
3.5
u/ml
28.3
33.5
0.69
612
2353
(3015736) pH of Urine
10469
63416
1.17
35.77
3.0
3.0
ph
5.9
5.8
—
7
47
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
286
837
2.33
35.70
1.9
1.7
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
94
2184
0.29
35.00
15.0
19.6
nmol/l
1434.0
2579.3
0.78
85
2101
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
1742
8585
1.40
34.62
3.9
3.3
u/ml
36.2
46.1
1.89
1675
8306
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
576
2253
1.75
32.22
1.4
1.2
mmol/l
6.7
7.3
4.52
422
1663
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
4320
34809
0.82
30.81
3.1
3.1
%
21.6
21.4
0.40
1405
12346
(3011397) Hemoglobin [Presence] in Urine by Test strip
6304
36985
1.19
30.43
3.3
3.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
5981
46526
0.84
28.81
3.9
4.1
mg/mmol
9.1
8.9
0.07
3792
29641
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
6301
37421
1.17
25.72
2.0
1.8
mg/l
1.1
1.0
0.23
4732
27836
(36304419) Bacteria [Presence] in Urine
6970
41734
1.17
25.67
2.9
2.9
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
5760
44414
0.85
24.16
3.3
3.3
mg/l
593.5
407.3
1.63
3644
27916
(3022621) pH of Urine by Test strip
1821
9579
1.31
23.47
2.6
2.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
1329
6689
1.36
23.17
1.5
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
7577
46009
1.15
22.62
3.1
3.0
e6/l
88.4
63.3
0.61
5665
34868
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
1059
5156
1.40
22.58
3.6
3.3
g/l
3.5
3.5
0.22
1017
4944
(3006245) CD3-CD19+ cells/100 cells in Blood
247
836
2.01
21.75
2.7
2.6
%
12.9
11.4
0.80
234
788
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
3405
19420
1.21
21.62
3.0
3.1
umol/l
7.3
7.8
0.67
2971
16755
(3029937) Albumin [Presence] in Urine by Test strip
7084
42925
1.15
21.62
3.6
3.6
estimate
0.0
0.0
2.22
2603
14473
(3013826) Glucose [Moles/volume] in Serum or Plasma
14917
94762
1.12
21.57
4.8
4.8
mmol/l
6.4
6.6
48.55
13674
88850
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
605
2693
1.53
20.44
1.4
1.4
u/l
25.2
27.8
1.13
508
2157
(40768793) Breast Pathology biopsy report
732
3396
1.47
20.28
1.3
1.3
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
622
2802
1.51
19.90
1.5
1.5
nmol/l
0.4
0.3
1.36
490
2109
(3045414) Leukocytes [Presence] in Urine
1349
6986
1.32
19.46
1.8
1.8
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
34
32
7.21
19.44
1.1
1.0
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
234
810
1.96
19.42
2.6
2.4
%
28.6
28.1
0.20
223
773
(3019150) Specific gravity of Urine by Refractometry
5955
35899
1.15
19.20
3.5
3.5
kg/l
1.0
1.0
1.24
919
4922
(36660697) Celiac disease serology panel - Serum
2806
15888
1.22
19.09
1.2
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
688
3192
1.47
19.09
2.0
2.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
2166
11959
1.24
18.75
1.6
1.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
529
2333
1.55
18.68
1.5
1.7
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
13412
85122
1.11
18.64
6.6
6.2
umol/l
10.9
11.1
0.61
12773
80637
(3047181) Lactate [Moles/volume] in Blood
942
4650
1.38
18.57
6.7
6.1
mmol/l
1.2
1.3
1.80
826
4094
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
461
1977
1.59
18.39
2.5
2.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
6895
42131
1.14
18.08
3.0
3.0
e6/l
0.3
0.4
4.15
5044
31142
(3013512) EKG study
5716
43320
0.87
18.08
3.0
3.3
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
59
104
3.85
17.81
1.0
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
2372
13319
1.22
17.50
1.2
1.2
iu/ml
153.6
145.7
0.34
906
5077
(3002256) Pathology report gross observation
3474
20220
1.18
17.44
1.3
1.2
—
—
—
0
0
(3039000) Anion gap in Blood
666
3133
1.45
17.25
8.0
7.5
mmol/l
11.1
11.3
1.28
597
2835
(3018572) Chloride [Moles/volume] in Blood
666
3134
1.45
17.22
8.0
7.5
mmol/l
105.2
105.2
0.01
597
2837
(3000060) B lymphocytes [#/volume] in Blood
194
660
2.00
16.98
2.6
2.5
e6/l
581.4
255.3
0.75
118
372
(3009508) Creatinine [Moles/volume] in Urine
6930
51657
0.88
16.71
3.3
3.3
mmol/l
8.2
8.2
0.66
6116
44571
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
4069
24076
1.17
16.64
2.7
2.7
e6/l
3.3
3.0
0.59
2119
12437
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
4892
29391
1.15
16.25
1.3
1.3
u/ml
9.2
11.8
1.93
1965
12151
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
160
517
2.10
16.08
2.4
2.4
ng/l
133.6
112.9
0.40
108
295
(3003157) Bacteria [#/volume] in Mother's milk
18
0
+∞
16.04
8.1
0.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
5185
31308
1.15
16.00
1.3
1.3
iu/ml
29.0
33.0
1.07
1668
9948
(3020564) Creatinine [Moles/volume] in Serum or Plasma
29485
196380
1.18
15.89
12.9
13.1
umol/l
71.7
74.1
50.95
29476
196291
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
3871
22919
1.16
15.64
1.7
1.7
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
326
1339
1.66
15.55
2.8
2.9
e9/l
0.2
0.2
0.23
276
1135
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
29641
197558
1.18
15.45
9.6
9.5
u/l
27.7
28.8
15.57
29021
192027
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
2662
15302
1.19
15.34
1.4
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
4761
28657
1.15
15.32
3.2
3.3
ng/l
531.2
575.8
0.20
3048
19622
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
1039
5369
1.32
15.28
3.4
2.9
%
172.2
183.1
3.96
995
5116
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2369
13506
1.20
14.92
4.6
4.1
ug/l
18.1
23.1
0.42
1839
10574
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
3287
25605
0.86
14.88
2.3
2.3
ug/l
0.6
0.6
0.55
1637
13296
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
431
1917
1.53
14.77
1.3
1.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
211
777
1.85
14.71
1.5
1.2
mmol/l
5.4
6.0
11.46
202
728
(3033658) Prothrombin time (PT) actual/Normal
6907
42692
1.12
14.53
4.2
4.2
%
95.5
94.1
5.74
6725
41567
(4035726)
2399
13730
1.20
14.49
1.4
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
2837
16483
1.18
14.44
2.4
2.3
nmol/l
13.3
13.4
0.11
2627
14997
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
328
1379
1.62
14.32
2.8
2.9
e6/l
572.3
512.4
1.39
275
1139
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
68
157
2.94
13.81
1.1
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
19900
129892
1.10
13.74
3.9
3.9
mm/h
9.6
10.3
16.02
18821
121693
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
2448
19393
0.84
13.59
5.5
5.6
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
40
65
4.17
13.46
1.1
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
7170
44599
1.11
13.30
1.3
1.3
u/ml
1.9
1.8
0.19
1864
12497
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
4284
25833
1.14
13.28
2.6
2.6
e6/l
0.9
1.0
1.59
2340
14143
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
1443
7923
1.24
13.15
1.1
1.1
u/ml
6.8
13.1
0.54
15
122
(4211845)
179
651
1.87
13.04
2.5
2.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
1979
11236
1.21
13.02
3.3
3.4
pmol/l
4.6
4.6
0.72
1825
10065
(3006462) Nitrate [Presence] in Urine
164
580
1.92
12.99
2.6
2.7
—
—
—
0
0
(3036489) Thrombin time
1242
6716
1.26
12.93
2.9
2.5
s
21.7
21.5
0.59
1070
5805
(3000850) Epithelial cells [#/volume] in Urine
5125
31313
1.13
12.91
2.6
2.5
e6/l
6.1
5.8
0.92
4480
27531
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
9802
62065
1.10
12.73
3.5
3.3
u/l
30.9
34.0
5.18
9420
59023
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
61
1050
0.39
12.57
2.3
2.4
nmol/l
161.5
152.9
0.32
55
904
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
1121
6028
1.27
12.25
3.4
2.9
%
93.6
94.0
0.20
1038
5630
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
566
2758
1.40
12.22
1.3
1.3
—
—
—
0
0
(44806118)
411
1893
1.48
12.03
1.8
1.6
—
—
—
0
0
(44790048)
411
1893
1.48
12.03
1.8
1.6
—
—
—
0
0
(44790049)
410
1893
1.47
11.86
1.8
1.6
—
—
—
0
0
(44790047)
410
1893
1.47
11.86
1.8
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
20404
133725
1.09
11.80
3.0
3.1
u/l
41.3
46.3
17.94
19561
127212
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
1061
5707
1.27
11.58
1.1
1.1
u/ml
6.6
5.4
0.25
150
875
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
1138
6188
1.26
11.34
1.4
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
953
5073
1.28
11.33
1.1
1.1
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
58
139
2.83
11.13
1.3
1.2
umol/l
83.4
84.7
0.09
51
128
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
1079
5846
1.26
11.10
1.3
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
1316
7295
1.23
11.03
1.1
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
316
1405
1.53
10.99
1.2
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
7143
44804
1.10
10.95
7.2
7.4
—
—
—
0
0
(3018738) Hemoglobin F/Hemoglobin.total in Blood
55
130
2.87
10.82
2.9
4.4
%
4.6
8.7
0.97
18
52
(3021440) Promyelocytes/100 leukocytes in Blood
1761
14068
0.84
10.75
4.1
4.5
%
0.2
0.1
1.78
448
3633
(1617658) Protocol used for examination of sentinel lymph nodes
264
1133
1.58
10.74
1.1
1.0
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
695
6138
0.76
10.72
3.8
4.0
%
49.5
51.1
0.94
689
6060
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
602
3033
1.35
10.65
1.3
1.3
u/ml
3.6
3.4
0.09
211
1072
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
588
2961
1.35
10.44
1.3
1.3
u/ml
3.8
4.1
0.28
260
1403
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
415
3936
0.71
10.33
2.3
2.5
nmol/l
0.9
0.8
0.42
364
3339
(3014148) Varicella zoster virus Ab [Titer] in Serum
546
2723
1.36
10.32
1.2
1.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
333
1521
1.49
10.24
2.4
2.3
%
12.8
13.1
0.19
222
759
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
571
2873
1.35
10.21
1.2
1.1
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
264
2695
0.66
9.84
2.3
2.9
mmol/l
1.3
1.5
9.75
253
2633
(3007164) IgA [Mass/volume] in Serum or Plasma
6252
39143
1.10
9.81
1.5
1.5
g/l
2.2
2.3
4.13
3945
24893
(1175426) CD3 cells/100 lymphocytes in Blood
334
1541
1.47
9.80
2.4
2.3
%
71.4
72.9
0.83
322
1488
(3013336) Amino acids [Identifier] in Serum or Plasma
46
104
3.00
9.79
3.2
2.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
1274
7135
1.22
9.71
1.3
1.3
miu/ml
233.8
219.8
0.70
623
3228
(40761536) Microorganisms panel - Urine sediment
2335
13787
1.16
9.67
3.5
3.6
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
241
2495
0.65
9.63
2.4
3.0
mmol/l
6.5
7.4
11.83
235
2448
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
413
1996
1.41
9.47
3.1
2.4
nmol/l
22.0
20.2
2.29
400
1896
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
311
1427
1.48
9.40
2.5
2.3
—
—
—
0
0
(4306422)
591
3029
1.33
9.38
1.2
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
1714
13559
0.85
9.32
3.8
4.2
%
0.6
0.6
0.10
354
2872
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
4747
35127
0.90
9.24
2.8
2.8
ng/l
648.5
904.5
5.38
3904
29079
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
238
1035
1.56
9.23
1.2
1.2
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
66
191
2.34
8.84
1.9
1.6
mg/l
1.5
1.6
0.08
37
138
(3017181) Myelocytes/100 leukocytes in Blood
1886
14744
0.86
8.82
4.0
4.5
%
1.0
0.9
1.18
490
3920
(3025159) Blasts/100 leukocytes in Blood
1701
13401
0.85
8.79
4.1
4.6
%
0.1
0.2
1.40
383
3103
(3033705) Calcium.ionized [Moles/volume] in Venous blood
114
1379
0.56
8.73
2.0
2.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
593
3075
1.31
8.71
1.2
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
570
2944
1.32
8.62
1.1
1.1
%
116.5
119.2
1.12
516
2684
(3011412) CD3 cells [#/volume] in Blood
387
1882
1.40
8.61
2.7
2.7
e9/l
1.4
1.2
3.45
249
1138
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
20020
131816
1.08
8.60
7.6
7.3
u/l
76.5
77.7
3.69
19108
124851
(3018133) Calcium [Moles/volume] in Urine
116
423
1.86
8.57
3.0
2.4
mmol/l
2.8
2.6
0.58
107
384
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
346
1660
1.42
8.34
4.5
4.8
u/ml
149.4
98.0
0.51
95
513
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
986
5468
1.23
8.33
1.2
1.2
—
—
—
0
0
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
64
188
2.31
8.32
1.9
1.6
mg/l
2.2
2.7
0.22
43
144
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
64
188
2.31
8.32
1.9
1.6
mg/l
1.2
1.1
0.05
39
130
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
64
188
2.31
8.32
1.9
1.6
mg/l
3.6
2.7
0.42
40
132
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
64
188
2.31
8.32
1.9
1.6
mg/l
1.5
1.8
0.35
42
145
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
64
188
2.31
8.32
1.9
1.6
mg/l
0.8
1.9
2.35
34
123
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
64
188
2.31
8.32
1.9
1.6
mg/l
2.4
1.5
0.73
44
142
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
64
188
2.31
8.32
1.9
1.6
mg/l
1.1
0.8
0.46
37
134
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
64
188
2.31
8.32
1.9
1.6
mg/l
2.4
2.3
0.04
38
133
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
64
188
2.31
8.32
1.9
1.6
mg/l
5.8
3.4
1.23
41
126
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
405
3713
0.74
8.24
2.6
2.4
ug/min
115.5
108.0
0.12
268
2315
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
774
4197
1.26
8.03
2.0
1.8
iu/l
24.6
8.6
0.55
300
1573
(3026782) Osmolality of Urine
4639
28899
1.10
7.92
2.6
2.7
mosm/kgh2o
554.5
547.6
1.11
3984
24874
(3041354) Potassium [Moles/volume] in Venous blood
122
1409
0.59
7.91
1.9
2.2
mmol/l
3.9
4.0
1.65
122
1396
(3035285) Chloride [Moles/volume] in Venous blood
122
1407
0.59
7.87
1.9
2.2
mmol/l
105.9
105.5
0.50
122
1394
(21494755) Public health laboratory ask at order entry panel
4311
26779
1.10
7.79
1.3
1.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
27565
184022
1.10
7.74
12.4
12.9
mmol/l
3.9
4.0
23.14
26941
179052
(3037121) Protein [Mass/volume] in Urine
925
5139
1.23
7.71
3.8
3.8
g/l
0.3
0.3
0.24
439
2516
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
155
638
1.65
7.62
2.4
1.8
%
156.7
164.4
0.33
147
610
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
581
3065
1.29
7.57
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
1891
11200
1.15
7.54
1.4
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
1907
11304
1.15
7.52
1.1
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
10943
70757
1.07
7.49
2.4
2.3
nmol/l
75.9
74.6
5.41
10267
65536
(3019550) Sodium [Moles/volume] in Serum or Plasma
27451
183284
1.09
7.45
12.3
12.8
mmol/l
139.8
139.7
5.37
26883
178719
(4268621)
413
2082
1.35
7.44
2.4
2.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
1381
8011
1.18
7.23
10.9
11.5
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
806
6648
0.82
7.04
3.8
3.7
mmol/l
25.6
25.3
1.67
768
6433
(3037522) Nuclear Ab [Titer] in Serum
4175
26018
1.10
7.03
1.4
1.4
titre
529.5
544.5
0.18
821
4922
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
194
861
1.53
7.01
2.4
1.8
%
132.8
141.8
0.99
187
817
(1761482) Bacteria [#/volume] in Urine by Culture
334
3064
0.74
6.91
3.1
3.5
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
813
6685
0.82
6.89
4.6
3.6
%
0.7
0.7
0.28
785
6416
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
621
3347
1.26
6.86
1.1
1.1
au/ml
9.4
13.1
0.61
46
224
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
1349
7852
1.17
6.80
1.8
1.8
nmol/l
37.6
37.3
0.17
1333
7704
(3005322) IgE [Units/volume] in Serum or Plasma
2158
12991
1.13
6.79
1.4
1.3
u/ml
203.9
272.6
2.98
2010
12030
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
1438
11239
0.86
6.75
2.0
2.1
ug/l
9.4
8.3
0.54
1310
10031
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
198
891
1.51
6.73
1.2
1.2
u/ml
4.9
17.6
1.62
23
101
(3028679) Herpes simplex virus Ab [Presence] in Serum
221
1018
1.47
6.71
1.2
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
1356
7909
1.17
6.67
1.3
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
668
3644
1.25
6.66
1.9
1.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
3178
19588
1.11
6.66
1.6
1.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
2615
15958
1.12
6.57
2.4
2.7
u/l
36.9
43.0
0.97
2269
13765
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
257
1225
1.42
6.54
1.2
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
125
1364
0.62
6.52
1.6
1.4
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
71
242
1.99
6.49
1.2
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
575
3093
1.26
6.48
1.1
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
11662
75861
1.06
6.38
2.4
2.6
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
55
171
2.18
6.37
1.2
1.3
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
714
3945
1.23
6.36
1.5
1.4
pmol/l
126.1
127.5
0.02
698
3845
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
1374
8054
1.16
6.35
1.6
1.7
mg/l
3.7
3.6
0.16
932
5650
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
246
1170
1.43
6.35
1.1
1.2
ratio
1.1
1.1
1.61
93
436
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
8171
52540
1.07
6.34
2.5
2.7
u/l
57.1
57.0
0.04
7667
48649
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
422
2198
1.30
6.15
1.2
1.1
%
95.2
98.7
1.75
399
2068
(3009466) Valproate [Moles/volume] in Serum or Plasma
368
3270
0.76
6.14
4.9
5.7
umol/l
384.2
383.5
0.03
326
2912
(3002523) Influenza virus A Ag [Presence] in Specimen
710
3937
1.23
6.13
1.1
1.1
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
309
1541
1.36
6.06
1.1
1.1
u/ml
1.7
7.1
1.62
97
451
(3025130) Human papilloma virus identified in Specimen
456
2408
1.29
6.01
1.7
1.7
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
174
783
1.51
5.97
1.2
1.1
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
75
269
1.89
5.97
2.4
1.7
pmol/l
31.2
62.7
1.08
67
229
(3003740) Influenza virus B Ag [Presence] in Specimen
708
3937
1.22
5.96
1.1
1.1
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
303
1512
1.36
5.93
3.4
3.2
mu/l
27.4
27.9
0.09
290
1410
(3018677) aPTT in Platelet poor plasma by Coagulation assay
3675
22952
1.10
5.89
2.7
2.4
s
29.6
29.7
0.31
3571
22323
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
1420
8397
1.15
5.86
2.0
1.8
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
178
809
1.49
5.84
1.2
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
48
663
0.49
5.84
1.4
2.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
341
1738
1.33
5.82
3.9
3.1
nmol/l
7.2
8.2
0.07
329
1678
(3004959) Base excess in Arterial cord blood by calculation
68
238
1.94
5.82
1.0
1.0
mmol/l
-2.4
-2.0
0.11
12
61
(3006598) pH of Arterial cord blood
68
238
1.94
5.82
1.0
1.0
—
—
—
0
0
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
68
238
1.94
5.82
1.0
1.0
kpa
7.2
7.4
0.45
57
203
(3021706) Oxygen [Partial pressure] in Arterial cord blood
67
235
1.93
5.71
1.0
1.0
kpa
3.1
3.2
0.26
56
201
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
393
2050
1.30
5.71
1.2
1.2
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
241
1168
1.40
5.65
1.4
1.3
umol/l
5.3
5.2
0.05
222
1066
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
4313
31385
0.92
5.65
1.6
1.6
pmol/l
53027131.9
37656544.9
0.75
3783
26904
(3024354) Oxygen [Partial pressure] in Venous blood
1572
12046
0.88
5.60
5.1
4.1
kpa
4.8
4.9
0.08
1525
11646
(3019309) Folate [Moles/volume] in Red Blood Cells
3158
23276
0.91
5.54
1.6
1.7
nmol/l
1135.4
1179.3
2.16
2525
18039
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
16
342
0.32
5.51
6.1
7.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
675
3768
1.22
5.51
1.9
1.7
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
139
607
1.55
5.50
1.2
1.1
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
119
503
1.61
5.41
1.4
1.3
umol/l
16.5
16.8
0.34
106
452
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
25587
170848
1.07
5.37
10.1
10.6
ml/min/173m2
90.0
88.3
31.73
20866
139640
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
217
1046
1.41
5.28
1.4
1.5
u/l
5.5
6.2
1.15
191
894
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
136
597
1.55
5.28
1.1
1.1
%
93.8
90.2
0.67
67
291
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
66
237
1.89
5.28
1.1
1.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
8137
52588
1.06
5.26
3.9
3.3
mmol/l
2.4
2.4
0.06
7436
46979
(3048689) Calprotectin [Mass/mass] in Stool
4037
25443
1.09
5.25
2.4
2.6
ug/g
108.5
131.8
3.88
3241
20323
(3020874) Milk IgE Ab [Units/volume] in Serum
311
1592
1.33
5.21
1.1
1.1
u/ml
2.3
4.0
0.59
110
523
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
164
753
1.48
5.18
1.1
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
2123
12994
1.11
5.11
2.3
2.3
au/ml
20.8
22.6
0.42
165
845
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
5639
36034
1.07
5.11
2.2
2.3
mg/l
2.7
2.8
4.44
4916
31215
(3043409) Potassium [Moles/volume] in Arterial blood
509
4246
0.81
5.09
3.9
4.7
mmol/l
3.8
3.9
2.15
482
4007
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
214
1037
1.40
5.08
6.2
6.8
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
308
1583
1.32
5.03
1.2
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
312
2752
0.77
5.02
3.7
2.9
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
462
3880
0.80
4.94
5.1
3.2
mmol/l
23.9
24.5
3.78
425
3428
(3022670) pH of Venous cord blood
24
57
2.85
4.85
1.1
1.0
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
2038
12483
1.11
4.85
2.2
2.8
e9/l
4.0
4.1
1.02
1720
10127
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
722
4114
1.19
4.80
1.9
1.6
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
1955
11955
1.11
4.80
1.3
1.3
au/ml
43.2
48.8
0.41
72
475
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
53
183
1.96
4.79
1.5
1.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
1136
8789
0.87
4.73
4.8
3.9
g/l
130.7
132.0
1.10
1098
8600
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1953
14623
0.90
4.72
5.5
4.7
kpa
5.9
5.8
0.49
1892
14189
(3018405) Lactate [Moles/volume] in Arterial blood
602
4898
0.83
4.71
3.6
4.5
mmol/l
1.4
1.4
0.04
597
4814
(40768800) Prostate Pathology biopsy report
217
1993
0.74
4.68
1.2
1.2
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
130
582
1.52
4.68
1.1
1.1
%
94.9
90.7
0.57
64
291
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
26
411
0.43
4.67
1.1
1.2
—
—
—
0
0
(1002224) Polysomnography panel
1637
9935
1.12
4.60
1.1
1.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
1811
11057
1.12
4.59
4.7
4.4
ng/l
77.8
88.6
5.42
1652
9803
(3049233) Organic acids panel - Urine
24
59
2.76
4.59
1.2
1.2
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
963
5645
1.16
4.57
1.9
2.0
pmol/l
205.9
204.7
0.14
927
5429
(3015076) Soybean IgE Ab [Units/volume] in Serum
273
1401
1.32
4.56
1.1
1.1
u/ml
0.5
1.0
0.65
49
223
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
4287
30949
0.93
4.54
1.7
1.9
%
1.3
1.4
6.82
3874
27946
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
135
614
1.49
4.52
1.2
1.2
%
109.3
105.0
0.50
125
559
(3003327) Ova and parasites identified in Stool by Light microscopy
1177
7005
1.14
4.52
1.7
1.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
6701
43238
1.06
4.48
2.4
2.5
umol/l
2501.6
3151.3
1.06
6044
38594
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
130
588
1.50
4.48
1.2
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
117
1185
0.67
4.47
2.6
2.3
ml
711.0
677.7
0.33
92
860
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
2514
15633
1.10
4.45
1.8
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
807
4678
1.17
4.43
2.5
3.0
—
—
—
0
0
(3020891) Body temperature
722
5744
0.85
4.39
4.5
5.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
860
5015
1.17
4.38
3.8
3.7
u/ml
539.6
2351.9
0.83
753
4306
(3013650) Neutrophils [#/volume] in Blood by Automated count
15631
103247
1.05
4.33
9.3
9.8
e9/l
3.8
4.0
17.46
13743
90940
(3028433) Virus identified in Specimen by Culture
128
583
1.49
4.28
1.2
1.2
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
60
225
1.81
4.28
1.5
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
1959
14582
0.90
4.25
5.5
4.7
mmol/l
1.7
1.8
0.36
1628
11950
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
331
1764
1.27
4.20
1.9
1.8
—
—
—
0
0
(3012544) pH of Venous blood
2030
15073
0.91
4.19
5.5
4.7
ph
7.4
7.4
—
9
75
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
562
3175
1.20
4.17
1.1
1.1
u/ml
2.9
3.2
0.16
262
1653
(3020961) Endomysium IgA Ab [Titer] in Serum
1647
10064
1.11
4.14
1.1
1.1
titre
320.1
202.8
0.45
42
292
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
740
4286
1.17
4.13
1.6
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
18185
120629
1.05
4.13
3.1
3.2
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
116
1155
0.68
4.10
4.4
7.1
u/ml
57.6
3247.1
0.86
12
298
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
137
640
1.45
4.06
1.1
1.1
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
178
872
1.39
4.06
1.1
1.1
%
95.8
101.8
1.60
142
710
(3045462) Protein/Creatinine [Ratio] in Urine
73
298
1.66
3.92
6.1
6.2
g/mol
63.3
237.1
0.55
63
279
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
483
2708
1.21
3.91
1.6
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
583
3327
1.19
3.90
1.1
1.2
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
75
310
1.64
3.85
1.1
1.1
mmol/l
19.9
20.2
0.34
69
269
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
168
826
1.38
3.78
1.2
1.2
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
62
245
1.72
3.76
1.3
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
405
3342
0.82
3.76
2.2
2.6
%
17.5
17.1
1.19
192
1702
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
2477
15518
1.09
3.75
1.8
1.7
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
672
3896
1.17
3.75
1.3
1.2
u/ml
52.2
44.6
0.48
67
394
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
89
387
1.56
3.73
1.3
1.2
%
76.0
75.4
0.03
26
112
(3007930) Methemoglobin/Hemoglobin.total in Blood
916
5444
1.14
3.67
6.5
5.5
%
1.0
0.9
2.01
844
5112
(3013005) Retinol [Moles/volume] in Serum or Plasma
194
982
1.34
3.65
2.3
2.2
umol/l
1.9
1.9
0.38
184
926
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
56
217
1.75
3.65
3.1
2.6
pmol/l
87.7
63.5
0.26
51
183
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
730
4273
1.16
3.62
1.6
1.6
u/ml
22.3
20.6
0.11
16
81
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
935
5571
1.14
3.61
6.4
5.4
%
1.7
1.8
1.82
858
5223
(3018010) Neutrophils/100 leukocytes in Blood
13181
86958
1.05
3.61
6.0
6.3
%
55.5
55.8
2.85
12478
82342
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
689
4016
1.17
3.61
1.6
1.6
u/ml
110.7
109.5
0.12
143
806
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
50
188
1.80
3.60
1.6
1.3
nmol/l
15.6
17.9
0.46
16
51
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
89
391
1.54
3.59
1.4
1.2
%
88.7
88.7
0.00
27
125
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
63
254
1.68
3.58
1.8
1.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
7011
45600
1.05
3.46
4.4
4.2
ph
7.4
7.4
0.27
1327
8852
(1616796) Gas panel - Central venous blood
441
3576
0.83
3.44
3.3
3.7
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
807
4784
1.15
3.39
1.4
1.4
ug/g
296.6
281.3
0.69
439
2718
(3026389) Candida sp identified in Specimen by Organism specific culture
456
2583
1.20
3.37
1.3
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
3540
22582
1.07
3.36
1.9
1.8
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
13353
88230
1.04
3.32
6.2
6.5
%
30.1
29.7
4.35
12604
83259
(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid
25
75
2.26
3.30
1.0
1.1
mg/l
2.0
0.0
0.48
19
69
(4062490)
369
2054
1.22
3.28
1.3
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
225
1184
1.29
3.26
2.2
2.4
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
252
1346
1.27
3.25
1.1
1.1
iu/ml
6.7
7.5
0.21
70
333
(3028026) IgM [Mass/volume] in Serum or Plasma
1785
11099
1.09
3.25
1.9
1.8
g/l
1.2
1.3
0.33
1660
10248
(3020491) Glucose [Moles/volume] in Blood
216
1133
1.29
3.21
1.8
1.7
mmol/l
6.0
7.2
8.81
180
797
(3029612) Listeria sp Ab [Titer] in Serum
8
9
6.02
3.21
1.3
1.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
291
2439
0.81
3.21
1.5
1.6
mmol/l
70.9
64.0
1.61
235
1871
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
961
5791
1.13
3.17
1.8
1.7
g/l
1.2
1.2
1.55
912
5539
(3027135) IgG subclass 1 [Mass/volume] in Serum
367
2051
1.21
3.16
1.3
1.4
g/l
6.5
6.6
0.18
257
1425
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
847
5066
1.14
3.15
1.3
1.3
u/ml
42.0
33.4
0.35
52
301
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
796
4742
1.14
3.14
1.4
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
3246
20696
1.07
3.14
1.5
1.5
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
366
2047
1.21
3.13
1.3
1.4
g/l
0.3
0.4
1.55
255
1428
(3002079) Sodium [Moles/time] in 24 hour Urine
11
21
3.55
3.13
1.2
1.2
mmol/24h
131.9
145.2
0.37
11
21
(3028192) IgG subclass 2 [Mass/volume] in Serum
366
2048
1.21
3.11
1.3
1.4
g/l
2.8
2.9
0.35
254
1433
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
1647
10226
1.10
3.11
3.2
2.7
ng/l
119.5
135.9
1.19
1484
9105
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
2491
15747
1.08
3.06
4.9
4.6
u/l
238.3
241.6
0.38
2373
14997
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
197
1715
0.78
3.04
1.1
1.1
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
12854
84978
1.04
3.04
6.5
6.8
%
8.3
8.5
6.29
12190
80530
(3015183) Erythrocyte sedimentation rate
215
1137
1.28
3.03
1.2
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
287
1572
1.24
3.01
2.0
1.9
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
171
878
1.32
3.00
2.4
2.3
umol/l
28.6
28.1
0.29
165
853
(42529406) Shigella sp [Presence] in Stool by Culture
884
5321
1.13
2.99
1.2
1.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
305
2521
0.82
2.97
3.8
3.0
%
1.3
1.4
0.19
257
1961
(3032868) Hemoglobin electrophoresis panel in Blood
51
206
1.68
2.94
1.6
1.5
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
114
551
1.40
2.93
1.1
1.3
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
129
1182
0.74
2.91
1.5
1.6
iu/ml
957840.6
1976123.8
—
9
89
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
512
2972
1.17
2.91
1.1
1.2
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
29
367
0.54
2.89
1.1
1.4
%
58.5
55.9
0.14
24
311
(3035637) Corticotropin [Mass/volume] in Plasma
429
2456
1.19
2.88
1.6
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
879
5303
1.13
2.88
1.2
1.2
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
52
213
1.66
2.86
3.2
3.3
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
896
5416
1.12
2.85
6.3
5.4
mg/l
1.2
1.4
6.28
846
5114
(3019897) Erythrocyte distribution width [Ratio] by Automated count
570
3344
1.16
2.84
2.2
2.4
%
13.1
13.1
0.01
564
3299
(3042631) Mycobacterium sp identified in Specimen
211
1804
0.79
2.84
2.9
2.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
872
5264
1.13
2.83
1.2
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
1778
11136
1.09
2.79
1.2
1.2
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
188
1624
0.78
2.77
11.8
11.9
mmol/l
0.6
0.6
0.64
174
1509
(44806420)
19
271
0.47
2.75
1.9
2.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
2643
19053
0.93
2.73
3.7
4.0
%
31.1
31.1
0.02
2025
13592
(4198724)
172
1499
0.78
2.73
1.9
2.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
374
3005
0.84
2.72
1.6
1.5
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
128
640
1.36
2.72
1.5
1.4
pmol/l
14.5
14.9
0.45
110
549
(3043410) Blood group antigens tested for on Red Blood Cells
79
362
1.48
2.72
1.7
1.8
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
13
31
2.84
2.69
1.7
1.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
12760
84492
1.04
2.69
6.2
6.6
%
2.9
2.9
0.20
12019
79653
(3022145) Colonoscopy Study observation
3068
19633
1.06
2.68
1.3
1.4
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
127
636
1.35
2.67
1.9
1.8
u/ml
552.3
8855.6
—
10
79
(3015171) Extractable nuclear Ab [Units/volume] in Serum
1189
7333
1.10
2.64
1.3
1.2
u/ml
0.8
0.9
0.16
84
654
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
186
986
1.28
2.63
1.1
1.1
nmol/l
0.8
5.9
1.69
37
177
(3022217) INR in Platelet poor plasma by Coagulation assay
2285
16529
0.93
2.62
15.6
16.2
inr
1.2
1.2
0.18
348
2538
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
7074
46313
1.04
2.60
1.7
1.7
mmol/l
1.4
1.5
3.38
6172
39696
(3014576) Chloride [Moles/volume] in Serum or Plasma
2594
18678
0.94
2.60
8.6
8.1
mmol/l
104.9
104.5
5.05
2537
18307
(40768797) Stomach Pathology biopsy report
3579
23036
1.06
2.59
1.2
1.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
12365
81875
1.04
2.58
6.3
6.6
%
0.7
0.7
1.19
11662
77188
(3028717) Thiamine [Mass/volume] in Blood
45
183
1.67
2.57
1.3
1.2
—
—
—
0
0
(4024509)
226
1231
1.25
2.56
1.4
1.6
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
777
4695
1.12
2.53
1.3
1.3
u/ml
7.3
12.1
1.35
137
718
(3022948) Iron [Moles/volume] in Serum or Plasma
3681
23738
1.06
2.50
2.5
2.6
umol/l
20.0
14.1
0.55
3440
22308
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
94
454
1.40
2.49
1.3
1.3
nmol/l
135.4
126.6
0.20
75
339
(3013945) Hepatitis B virus e Ab [Presence] in Serum
8
142
0.38
2.48
2.4
1.5
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
8
144
0.38
2.48
2.4
1.5
—
—
—
0
0
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
33
124
1.80
2.48
3.3
3.1
pmol/l
14.2
599.3
—
7
48
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
509
2997
1.15
2.47
1.0
1.1
u/ml
0.8
0.5
0.38
129
699
(3013931) Oligosaccharides [Presence] in Urine
7
10
4.74
2.46
1.1
1.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
765
4627
1.12
2.46
1.3
1.3
u/ml
2.3
9.0
3.84
88
464
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
515
3038
1.15
2.44
1.2
1.3
—
—
—
0
0
(42870560) Thyrotropin [Units/volume] in Cord blood
70
321
1.48
2.44
1.0
1.0
mu/l
8.0
8.7
0.45
58
280
(3005719) IgG [Mass/volume] in Serum or Plasma
2251
14309
1.07
2.43
2.8
2.7
g/l
10.3
10.5
1.01
2085
13149
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
23725
162445
0.96
2.43
4.4
5.0
mmol/mol
38.1
39.0
49.26
22605
153213
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
515
3040
1.15
2.42
1.2
1.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
141
730
1.31
2.41
1.3
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
238
1314
1.23
2.41
1.2
1.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
548
3251
1.14
2.40
1.5
1.6
g/l
0.7
0.7
0.40
409
2469
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
231
1272
1.23
2.39
2.6
2.8
%
97.2
96.8
0.07
220
1204
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
1125
6957
1.10
2.39
1.7
1.7
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
236
1303
1.23
2.39
1.2
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
669
5096
0.89
2.37
2.2
2.2
ug/l
2.3
2.5
0.13
598
4622
(3045424) Erythrocytes [Presence] in Urine
485
2855
1.15
2.37
1.6
1.5
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
158
833
1.29
2.37
3.3
2.6
ug/l
1.3
1.2
0.25
150
770
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
8179
57061
0.96
2.37
2.6
3.0
ng/l
28.1
53.4
1.80
4160
33348
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
83
396
1.42
2.37
1.1
1.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
921
5644
1.11
2.36
1.9
1.7
g/l
0.2
0.2
1.39
869
5387
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
262
1466
1.21
2.33
1.3
1.3
—
—
—
0
0
(4146454)
173
1473
0.79
2.32
2.6
2.8
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
742
4498
1.12
2.32
1.4
1.4
u/ml
246.7
256.9
0.49
484
2817
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
279
1572
1.20
2.32
1.1
1.1
mg/l
292.7
475.4
0.48
250
1419
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
10601
70109
1.04
2.31
6.7
6.4
mmol/l
1.2
1.2
2.69
9864
64278
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
69
320
1.46
2.29
3.6
5.1
u/l
54.8
65.2
0.21
29
118
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
138
720
1.30
2.26
1.0
1.0
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
24
84
1.94
2.24
6.0
6.6
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
54
239
1.53
2.24
1.2
1.1
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
5
106
0.32
2.20
1.6
1.9
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
69
324
1.44
2.17
1.6
1.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
598
3596
1.13
2.16
1.3
1.4
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
618
3724
1.13
2.16
1.1
1.1
u/ml
5.4
5.0
0.19
257
1553
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
8667
60307
0.96
2.16
1.8
1.8
pmol/l
98.9
98.1
0.76
4600
31586
(40760888) Immunoglobulin light chains.free panel - Serum
362
2852
0.86
2.15
3.5
3.3
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
2619
16804
1.06
2.15
2.2
2.3
nmol/l
369.8
369.5
0.03
2452
15580
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
858
6406
0.91
2.15
1.6
1.6
iu/ml
0.3
7.2
1.18
171
1292
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
11666
77361
1.03
2.14
7.3
7.0
mmol/l
1.2
1.2
1.87
9980
65880
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
50
220
1.54
2.14
1.4
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
841
5161
1.11
2.13
1.1
1.1
u/ml
2.1
2.0
0.09
378
2292
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
334
1930
1.17
2.12
1.1
1.1
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
422
2484
1.15
2.11
3.1
3.3
u/ml
38.9
663.4
0.97
382
2441
(3003888) Timothy IgE Ab [Units/volume] in Serum
767
4688
1.11
2.10
1.1
1.1
u/ml
5.5
6.1
0.51
422
2567
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
533
3191
1.13
2.08
4.4
3.5
u/ml
1041.1
6406.2
0.90
27
170
(3051101) Glucose [Moles/volume] in Cord blood
14
199
0.48
2.08
4.3
5.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
386
2260
1.16
2.08
1.5
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
248
1399
1.20
2.08
1.4
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
25660
172438
1.04
2.07
3.7
4.0
mmol/l
5.7
5.8
91.64
24256
161029
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
416
3233
0.87
2.07
1.1
1.1
iu/ml
19829.7
368.8
0.52
118
753
(3008401) Mugwort IgE Ab [Units/volume] in Serum
734
4488
1.11
2.01
1.1
1.1
u/ml
1.3
1.2
0.14
334
2053
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
330
1916
1.17
2.00
1.1
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
181
1504
0.81
1.99
1.4
1.6
—
—
—
0
0
(3016750) Collection duration of Urine
102
907
0.76
1.99
2.4
2.3
min
502.2
497.8
0.20
82
714
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
38
160
1.61
1.98
1.1
1.1
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
1432
10413
0.93
1.97
5.1
4.2
kpa
5.1
5.1
1.50
1347
9745
(3024869) Neuronal Ab [Presence] in Serum
56
258
1.47
1.97
1.1
1.1
—
—
—
0
0
(4094501)
804
4947
1.10
1.96
1.1
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
85
423
1.36
1.96
1.1
1.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
14037
93466
1.03
1.95
6.3
6.8
e9/l
0.2
0.2
0.89
12480
83057
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
176
967
1.23
1.94
1.4
1.3
%
63.9
65.2
0.06
19
113
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
453
2699
1.14
1.94
1.9
1.8
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
491
3755
0.88
1.93
3.2
3.1
umol/l
33.8
34.9
0.50
433
3298
(3017354) Segmented neutrophils/100 leukocytes in Blood
181
1498
0.82
1.93
3.1
3.1
%
54.9
57.5
1.01
134
959
(3000330) Specific gravity of Urine by Test strip
1048
6536
1.09
1.92
2.5
3.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
42
183
1.56
1.91
1.1
1.1
—
—
—
0
0
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
46
205
1.52
1.90
1.3
1.5
u/ml
0.9
9.3
1.71
38
169
(3042628) Porphyrins [Moles/volume] in Urine
5
7
4.84
1.90
1.2
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
20
244
0.56
1.87
1.2
1.6
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
574
3481
1.12
1.86
1.1
1.1
u/ml
5.5
6.1
0.29
247
1547
(3045177) Copper [Moles/volume] in Urine
12
34
2.39
1.86
1.2
1.0
umol/l
0.8
0.3
—
7
16
(3009343) pH of Capillary blood
1417
10278
0.93
1.84
5.1
4.2
ph
7.4
7.4
0.72
146
1270
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
162
888
1.24
1.84
1.8
2.1
u/l
200.7
198.4
0.10
162
883
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
65
313
1.41
1.84
1.2
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
48
474
0.69
1.83
2.6
2.7
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
724
4451
1.10
1.82
1.1
1.1
u/ml
2.5
2.8
0.17
205
1183
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
369
2179
1.15
1.82
1.8
1.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
288
1670
1.17
1.81
1.2
1.2
—
—
—
0
0
(3038702) Sodium [Moles/volume] in Capillary blood
6
11
3.70
1.80
6.8
2.5
mmol/l
140.2
138.7
—
6
11
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
39
170
1.56
1.79
1.1
1.1
umol/24h
1.9
4.0
0.48
39
170
(3011897) Casein IgE Ab [Units/volume] in Serum
94
483
1.32
1.79
1.2
1.3
u/ml
5.4
11.7
0.60
23
120
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
269
1553
1.18
1.79
1.3
1.2
g/l
1.5
1.4
0.07
15
65
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
170
941
1.23
1.77
1.1
1.1
miu/ml
1468.3
1483.3
0.07
170
941
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
66
321
1.39
1.77
1.3
1.2
mg/l
133.9
39.7
0.56
48
228
(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay
7
15
3.16
1.77
2.9
1.7
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
64
597
0.73
1.77
6.1
4.0
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
14
44
2.16
1.75
1.1
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
86
438
1.33
1.75
1.2
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
1722
12382
0.94
1.74
3.5
3.9
mmol/l
1.2
1.2
0.89
1535
10930
(21494567) Legionella sp IgM Ab [Presence] in Serum
28
113
1.68
1.73
1.1
1.1
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
84
427
1.33
1.73
2.1
1.7
nmol/l
0.2
0.2
0.11
71
309
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
15
49
2.07
1.72
1.0
1.1
—
—
—
0
0
(3032641) Amino acids panel - Urine
15
49
2.07
1.72
1.3
1.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
477
3623
0.89
1.72
3.4
3.3
ratio
3.6
1.9
0.31
41
310
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
1225
7731
1.08
1.71
2.0
2.1
u/l
40.2
40.0
0.14
1126
7050
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
130
702
1.26
1.71
1.5
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
130
702
1.26
1.71
1.6
1.7
—
—
—
0
0
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
36
156
1.56
1.70
1.0
1.0
u/ml
0.9
2.3
0.66
29
112
(3001604) Monocytes [#/volume] in Blood
13515
90074
1.03
1.70
6.1
6.4
e9/l
0.5
0.6
30.26
11777
79023
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
639
3921
1.11
1.70
1.2
1.3
—
—
—
0
0
(3002481) Calcium/Creatinine [Mass Ratio] in Urine
6
12
3.39
1.67
8.0
4.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
14003
93389
1.03
1.67
6.0
6.4
e9/l
1.9
2.0
3.52
12483
83359
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
30
125
1.63
1.66
4.3
4.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
46
448
0.70
1.66
4.9
7.3
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
68
337
1.37
1.66
1.1
1.1
umol/24h
1.5
5.0
0.38
39
169
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
54
257
1.42
1.66
2.1
2.0
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
769
4771
1.09
1.64
1.5
1.4
mg/l
497.1
536.8
0.73
731
4554
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
201
1617
0.84
1.64
1.4
1.3
nmol/l
1.4
1.4
0.09
189
1452
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
16
55
1.97
1.62
1.1
1.1
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
194
1100
1.20
1.62
1.8
1.5
ug/l
8.4
7.1
0.43
171
1002
(3000492) Spirometry study
3118
20268
1.05
1.62
1.4
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
347
2061
1.14
1.61
1.6
1.5
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
24
95
1.71
1.61
1.2
1.3
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
54
259
1.41
1.60
2.8
2.9
u/l
1885.6
2355.1
0.15
45
239
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
193
1554
0.84
1.60
1.5
1.6
%
39.1
33.1
1.17
108
972
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
21
80
1.78
1.59
1.5
1.9
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
50
237
1.43
1.58
7.2
4.4
mg/l
2.3
2.4
0.17
44
205
(3012494) Peanut IgE Ab [Units/volume] in Serum
143
789
1.23
1.58
1.1
1.1
u/ml
3.8
23.6
1.00
91
491
(3034860) Kappa light chains.free [Mass/volume] in Serum
494
3723
0.90
1.58
3.4
3.3
mg/l
41.3
61.5
0.70
404
2970
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
57
277
1.40
1.57
2.4
2.6
—
—
—
0
0
(4034850)
761
5615
0.92
1.57
7.7
7.9
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
25
101
1.68
1.57
1.0
1.0
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
63
312
1.37
1.56
1.1
1.1
u/ml
1.5
3.9
1.38
47
248
(3001218) Citrate [Mass/time] in 24 hour Urine
0
31
0.00
1.56
0.0
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
104
888
0.79
1.55
1.7
1.5
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
495
3725
0.90
1.54
3.4
3.3
mg/l
29.8
41.8
1.85
406
2970
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
19
71
1.81
1.54
1.2
1.2
ug/l
93.1
133.7
0.85
12
41
(3019225) pH of Specimen
1952
13919
0.95
1.52
3.6
4.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
13540
90347
1.03
1.52
6.1
6.5
e9/l
0.0
0.0
14.17
11785
79264
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
670
4150
1.10
1.51
7.0
6.5
iu/ml
311.9
1875.5
0.86
92
606
(3017569) Oxygen content in Arterial blood
67
602
0.75
1.49
2.1
2.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
57
280
1.38
1.49
1.5
1.5
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
77
678
0.77
1.48
2.8
2.9
umol/l
27.1
28.7
0.49
57
520
(3039162) Centromere protein B Ab [Units/volume] in Serum
393
2369
1.13
1.48
1.3
1.3
u/ml
42.0
55.7
0.54
25
149
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
256
1500
1.16
1.47
2.8
2.8
e6/l
775.6
713.3
0.59
92
544
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
149
833
1.21
1.47
1.2
1.4
%
72.9
73.7
0.29
142
793
(3045683) HLA typing for celiac disease panel - Blood or Tissue
234
1362
1.17
1.47
1.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
7
107
0.44
1.46
1.1
1.1
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
30
130
1.56
1.46
4.7
4.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
1913
13628
0.95
1.45
9.6
9.2
mmol/l
7.6
8.4
7.81
1851
13119
(3021960) Folate [Moles/volume] in Serum or Plasma
4553
31816
0.96
1.44
1.5
1.5
nmol/l
20.6
20.4
0.38
4048
27955
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
88
465
1.28
1.43
1.1
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
89
471
1.28
1.43
1.1
1.1
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
18
68
1.79
1.42
1.0
1.0
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
40
186
1.46
1.42
1.4
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
1175
8482
0.94
1.40
2.2
2.2
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
61
307
1.35
1.40
1.1
1.1
u/ml
8.7
5.3
0.27
47
248
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
26
110
1.60
1.40
1.1
1.1
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
56
278
1.37
1.40
1.1
1.1
u/ml
0.0
0.1
1.19
42
160
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
208
1206
1.17
1.39
1.3
1.3
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
79
414
1.29
1.38
1.5
1.3
%
46.9
40.9
0.59
51
290
(3004451) EKG impression Narrative
71
624
0.77
1.37
1.3
1.3
—
—
—
0
0
(3005067) clonazePAM [Moles/volume] in Serum or Plasma
0
28
0.00
1.37
0.0
3.1
—
64.6
—
0
21
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
1387
9950
0.94
1.37
5.1
4.2
mmol/l
1.2
1.5
4.02
993
7343
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
304
1815
1.14
1.36
1.9
1.7
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
31
138
1.52
1.36
1.1
1.0
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
686
4279
1.09
1.35
1.6
1.6
e6/l
1421.0
2485.1
0.52
548
3422
(3028468) Fragments [Presence] in Blood by Light microscopy
5
11
3.08
1.34
1.0
3.2
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
115
633
1.23
1.34
1.2
1.2
%
103.9
111.4
1.86
103
571
(3032080) INR in Blood by Coagulation assay
8922
59289
1.03
1.34
6.4
6.8
inr
1.1
1.1
2.65
2643
18268
(3050794) Legionella sp Ab [Presence] in Serum
32
144
1.51
1.34
1.2
1.1
—
—
—
0
0
(3010421) pH of Blood
571
4229
0.91
1.34
3.2
3.9
ph
7.4
7.4
2.66
493
3593
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
685
4276
1.09
1.33
1.5
1.5
e6/l
21.0
36.9
1.32
526
3230
(3010838) Calcium [Moles/time] in 24 hour Urine
152
862
1.20
1.32
1.5
1.6
mmol/24h
6.2
5.9
0.09
17
73
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
145
819
1.20
1.32
1.2
1.4
mu/l
434.4
544.6
1.22
138
779
(3022493) Free Hemoglobin [Mass/volume] in Plasma
135
758
1.21
1.31
7.8
6.7
mg/l
2938.4
3700.5
0.13
104
562
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
14
50
1.90
1.31
1.0
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
243
1436
1.15
1.28
1.5
1.4
umol/l
10.8
11.8
2.34
235
1368
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
81
0.42
1.28
7.0
5.6
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
122
680
1.22
1.28
1.2
1.2
g/l
0.3
0.3
0.94
96
547
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
6
16
2.54
1.26
1.0
1.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
10245
68250
1.02
1.26
5.4
5.1
g/l
36.7
36.5
2.75
9662
63773
(3020717) Zinc [Moles/volume] in Serum or Plasma
182
1054
1.17
1.26
1.7
1.6
umol/l
25.8
24.7
0.19
170
1013
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
44
214
1.39
1.26
1.1
1.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
3331
21816
1.04
1.26
2.5
2.6
g/l
2.4
2.4
0.12
3111
20419
(42870588) Differential panel, method unspecified - Blood
9084
60433
1.03
1.25
6.5
6.5
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
168
1334
0.85
1.25
3.2
2.8
nmol/l
0.7
0.8
1.22
119
976
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
16
61
1.78
1.25
1.1
1.6
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
67
349
1.30
1.25
2.4
2.5
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
104
572
1.23
1.25
1.9
1.5
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
51
255
1.36
1.25
1.2
1.4
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
41
383
0.73
1.23
1.5
1.4
g/l
13.5
12.7
0.20
29
282
(3044290) Cell count panel - Cerebral spinal fluid
644
4027
1.09
1.23
1.6
1.5
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
132
1067
0.84
1.22
3.5
3.4
mg/l
7.4
8.6
1.63
107
870
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
128
722
1.20
1.21
1.2
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
198
1160
1.16
1.20
2.0
1.9
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
12
42
1.94
1.19
1.4
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
39
188
1.41
1.19
1.4
1.4
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
29
132
1.49
1.18
1.1
1.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
3087
20219
1.04
1.18
2.6
2.7
%
24.3
23.8
1.27
2610
17659
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
97
803
0.82
1.16
1.8
1.6
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
50
253
1.34
1.15
1.0
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
21
219
0.65
1.15
2.3
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
11968
79953
1.02
1.15
8.7
9.2
e9/l
0.0
0.0
0.06
9722
65801
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
677
4258
1.08
1.14
1.4
1.4
mmol/l
3.6
3.7
3.53
638
3995
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
19
202
0.64
1.14
3.5
3.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
194
1141
1.15
1.13
1.3
1.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
1194
7657
1.06
1.13
2.5
2.6
e6/l
0.2
0.3
0.57
1142
7425
(3035880) pH of Pleural fluid
65
560
0.79
1.12
1.2
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
177
1035
1.16
1.12
1.1
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
2167
15273
0.96
1.11
2.9
3.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
99
811
0.83
1.09
1.8
1.6
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
14
158
0.60
1.08
1.3
1.2
mmol/l
4.1
5.7
—
7
83
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
12
141
0.58
1.08
1.0
1.0
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
502
3694
0.92
1.07
3.2
4.0
kpa
9.2
8.9
2.82
495
3617
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
63
334
1.28
1.07
1.2
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
572
4184
0.93
1.06
1.4
1.4
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
499
3668
0.92
1.05
3.2
4.0
kpa
5.0
5.0
2.04
492
3592
(3032743) Legionella sp IgG Ab [Presence] in Serum
24
108
1.51
1.05
1.2
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
499
3667
0.92
1.04
3.2
4.0
mmol/l
2.2
2.4
0.59
336
2491
(3032057) Clostridioides difficile [Presence] in Stool
31
293
0.72
1.04
1.7
1.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
1845
11998
1.04
1.03
1.2
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
276
2085
0.90
1.03
1.1
1.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
425
3142
0.92
1.03
1.2
1.2
titre
197.8
133.3
—
9
60
(3036071) Salmonella sp Ab [Titer] in Serum
125
717
1.18
1.02
1.1
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
261
1580
1.12
1.01
1.5
1.4
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
7
92
0.52
1.01
1.6
1.3
nmol/l
386.5
577.7
—
7
92
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
55
289
1.29
1.01
1.1
1.1
u/ml
0.0
1.1
1.87
29
153
(3041184) Isoniazid [Presence] in Urine
0
20
0.00
1.00
0.0
2.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
194
1154
1.14
1.00
2.9
2.8
%
40.0
39.5
0.14
93
355
(3033799) Differential panel - Peritoneal fluid
54
467
0.78
0.99
1.8
2.1
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
56
482
0.79
0.99
1.4
1.4
%
44.9
51.5
0.60
46
407
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
121
963
0.85
0.98
2.8
2.9
au/ml
161.3
144.2
0.12
23
126
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
188
1118
1.14
0.98
2.1
2.0
mg/l
3.2
3.5
0.62
178
1076
(3032352) Blasts [#/volume] in Cerebral spinal fluid
40
202
1.34
0.97
2.5
3.5
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
60
321
1.27
0.97
2.4
2.0
ug/l
2.1
3.2
0.64
34
200
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
122
703
1.18
0.96
1.9
1.9
—
—
—
0
0
(3003771) Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay
7
24
1.98
0.96
1.3
1.1
%
80.9
84.3
—
7
18
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
6
82
0.50
0.96
13.8
9.9
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
39
350
0.75
0.96
1.4
3.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
236
1427
1.12
0.95
1.3
1.2
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
8
100
0.54
0.95
1.0
1.0
—
—
—
0
0
(3036603) Volume of Urine
186
1109
1.14
0.94
1.5
1.7
ml
2445.5
1902.9
1.70
26
215
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
68
371
1.24
0.94
1.6
1.6
ug/l
0.4
0.4
0.36
47
272
(3002173) Hemoglobin [Mass/volume] in Arterial blood
2066
13502
1.04
0.93
9.4
9.5
g/l
123.8
123.9
0.05
1971
13033
(3013637) Mi-2 Ab [Presence] in Serum
48
417
0.78
0.93
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
48
417
0.78
0.93
1.1
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
48
417
0.78
0.93
1.3
1.3
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
48
417
0.78
0.93
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
48
417
0.78
0.93
1.1
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
1140
7353
1.05
0.92
2.4
2.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
121
700
1.17
0.92
1.5
1.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
5800
38522
1.02
0.92
4.2
4.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
63
529
0.81
0.92
2.3
2.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
268
1637
1.11
0.91
1.1
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
243
1832
0.90
0.91
1.1
1.1
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
9
107
0.57
0.90
2.4
2.0
—
—
—
0
0
(3003577) Lead [Moles/volume] in Blood
38
193
1.33
0.90
1.4
1.5
umol/l
0.2
0.2
0.64
11
75
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
884
5668
1.06
0.90
1.9
1.9
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
12
47
1.73
0.89
1.1
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
663
4785
0.94
0.89
1.5
1.8
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
44
229
1.30
0.89
1.4
1.4
%
22.5
27.2
0.52
36
193
(3008152) Bicarbonate [Moles/volume] in Arterial blood
1332
8635
1.05
0.89
7.4
7.7
mmol/l
24.6
24.7
0.19
1226
8046
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
595
3771
1.07
0.88
1.3
1.3
u/ml
1.7
4.9
1.95
46
282
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
358
2224
1.09
0.88
1.4
1.3
pmol/l
85.6
130.8
0.57
115
689
(3020191) Ethanol [Moles/volume] in Serum or Plasma
265
1984
0.90
0.88
1.6
1.5
promille
1.3
1.5
1.63
207
1533
(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum
32
159
1.36
0.87
1.1
1.0
u/ml
19.7
22.1
0.12
27
127
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
26
244
0.72
0.87
1.2
1.2
ug/l
48.8
310.8
1.61
15
128
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
26
125
1.41
0.86
5.4
4.6
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
57
309
1.25
0.85
1.8
1.5
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
107
618
1.17
0.85
1.2
1.4
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
485
3531
0.93
0.85
1.7
2.5
titre
3.2
7.4
—
5
139
(3051651) Icteric interference index of Serum or Plasma
172
1030
1.13
0.84
2.9
4.0
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
235
1434
1.11
0.84
1.5
1.3
u/ml
1.9
1.2
0.45
98
575
(4133840)
83
670
0.84
0.84
1.1
1.2
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
6
21
1.94
0.83
1.0
1.0
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
93
533
1.18
0.82
6.5
6.7
mmol/l
25.2
25.3
0.08
86
497
(3042951) Complement C1q Ab [Units/volume] in Serum
18
81
1.51
0.82
1.1
1.2
u/ml
21.9
21.8
—
6
14
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
58
317
1.24
0.82
1.1
1.0
ug/l
75.7
84.0
0.90
48
265
(3008838) Polymorphonuclear cells/100 leukocytes in Peritoneal fluid
0
17
0.00
0.81
0.0
2.2
—
22.3
—
0
6
(3023410) Appearance of Cerebral spinal fluid
330
2052
1.09
0.81
1.8
1.8
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
51
275
1.26
0.81
1.0
1.0
u/ml
0.2
0.2
0.14
34
170
(3008757) Leukocyte morphology finding [Identifier] in Blood
227
1703
0.90
0.80
3.7
3.5
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
59
324
1.23
0.80
1.2
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
3437
22722
1.03
0.80
2.0
2.1
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
26
127
1.39
0.80
1.3
1.4
%
68.6
67.6
0.05
21
108
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
6
22
1.85
0.79
1.0
1.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
71
577
0.83
0.78
2.1
2.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
248
1525
1.10
0.78
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
248
1525
1.10
0.78
1.2
1.2
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
168
1011
1.13
0.78
30.7
26.3
ug/l
122.8
122.7
0.01
131
830
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
83
474
1.19
0.77
1.2
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
202
1230
1.11
0.77
1.3
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
1948
13635
0.97
0.77
2.5
2.5
ml/min/173m2
75.1
71.4
3.53
686
4980
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
31
276
0.76
0.76
11.6
9.1
mmol/l
5.0
5.7
1.39
31
276
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
248
1528
1.10
0.76
1.2
1.2
—
—
—
0
0
(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid
8
91
0.60
0.75
5.6
5.7
mmol/l
17.9
16.7
—
8
85
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
83
476
1.18
0.75
1.2
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
123
728
1.15
0.74
1.2
1.2
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
6
74
0.55
0.74
1.2
1.1
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
26
129
1.37
0.74
1.4
1.2
—
—
—
0
0
(44813793)
216
1615
0.91
0.74
1.1
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
73
587
0.84
0.73
1.6
1.6
ug/l
8.1
8.9
1.54
73
587
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
872
5631
1.05
0.73
2.0
1.8
g/l
1.3
1.5
8.12
740
4843
(3026250) Tacrolimus [Mass/volume] in Blood
188
1145
1.11
0.73
36.8
38.2
ug/l
7.3
7.4
0.55
175
1062
(3027923) C peptide [Moles/volume] in Serum or Plasma
132
1014
0.88
0.73
1.6
1.6
nmol/l
1.4
1.2
1.28
107
808
(3011325) HIV 1+2 Ab [Presence] in Serum
20
95
1.43
0.72
1.0
1.1
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
9
38
1.60
0.72
1.2
1.1
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
157
1192
0.89
0.72
2.0
1.9
g/24h
1.1
0.9
0.22
18
93
(40761535) Cells panel - Urine sediment
1714
12001
0.97
0.71
3.5
3.3
—
—
—
0
0
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
53
293
1.23
0.70
1.1
1.1
u/ml
0.1
4.0
1.14
25
155
(3049242) von Willebrand panel - Platelet poor plasma
12
51
1.59
0.70
1.2
1.6
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
549
3945
0.94
0.70
3.3
3.5
e9/l
3.8
4.0
1.07
549
3937
(3048879) Bone marrow aspiration report
39
332
0.80
0.69
2.6
2.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
259
1609
1.09
0.69
2.8
3.5
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
324
2369
0.93
0.68
1.3
1.2
u/l
33.3
30.0
0.17
287
2080
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
104
613
1.15
0.68
2.0
2.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
104
613
1.15
0.68
2.0
2.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
1958
13666
0.97
0.68
10.4
9.8
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
102
601
1.15
0.68
1.2
1.2
—
—
—
0
0
(3012920) Ethanol [Mass/volume] in Serum or Plasma
13
57
1.55
0.67
1.5
1.3
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
69
552
0.85
0.67
1.8
2.1
e6/l
758.2
1120.9
0.68
45
373
(3040151) Glucose [Moles/volume] in Capillary blood
220
1633
0.91
0.67
3.9
9.9
mmol/l
6.7
7.4
2.93
178
1349
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
248
1541
1.09
0.66
1.2
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
150
1135
0.90
0.66
1.6
1.5
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
92
539
1.16
0.66
1.2
1.2
u/ml
10.8
9.6
0.07
66
388
(21494815) CD4 cells/100 lymphocytes in Specimen
300
1880
1.08
0.66
2.5
2.4
%
45.5
41.8
0.82
38
231
(3044927) Protein electrophoresis panel - Urine
146
1106
0.89
0.66
1.1
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
631
4506
0.95
0.66
2.8
2.5
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
248
1542
1.09
0.66
1.2
1.2
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
1031
7275
0.96
0.65
1.5
1.6
u/ml
12.7
11.7
0.11
29
221
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
88
0.62
0.65
1.1
1.1
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
162
1219
0.90
0.65
1.1
1.1
nmol/l
436.6
403.5
1.49
157
1101
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
248
1543
1.09
0.65
1.2
1.2
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
45
247
1.23
0.65
1.4
1.4
nmol/l
702949.0
245546.7
0.55
34
213
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
77
446
1.17
0.64
1.1
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
281
1759
1.08
0.64
1.2
1.1
mg/l
39.8
43.1
0.55
246
1451
(40763590) HLA-DQ beta [Type]
19
92
1.40
0.64
1.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
19
92
1.40
0.64
1.3
1.2
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
47
260
1.23
0.64
1.1
1.1
u/ml
0.9
0.4
0.37
26
142
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
1659
10899
1.03
0.63
9.6
8.8
mmol/l
24.7
24.8
1.22
1654
10821
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
26797
180969
1.02
0.63
3.9
4.0
mmol/l
1.5
1.4
20.46
25601
171088
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
273
1709
1.08
0.63
1.1
1.1
mg/l
247.5
269.6
0.92
249
1482
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
213
1320
1.09
0.62
1.8
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
213
1320
1.09
0.62
1.8
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
213
1320
1.09
0.62
1.8
1.8
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
65
518
0.85
0.62
1.4
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
475
3411
0.94
0.62
6.3
4.4
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
429
2733
1.06
0.62
1.1
1.1
g/l
1.4
1.5
2.69
390
2480
(3035153) Lemon IgE Ab [Units/volume] in Serum
0
15
0.00
0.61
0.0
1.1
—
—
—
0
0
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
24
213
0.76
0.61
1.1
1.3
mg/l
56.0
48.9
0.40
11
55
(40760409) HLA-A [Type] by High resolution
19
93
1.38
0.61
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
19
93
1.38
0.61
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
19
93
1.38
0.61
1.0
1.0
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
175
1305
0.91
0.61
1.4
1.4
g/l
35.9
35.4
0.25
155
1195
(3008116) Ketones [Moles/volume] in Urine by Test strip
46
377
0.83
0.60
1.8
1.5
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
49
399
0.83
0.60
1.3
1.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
53
428
0.84
0.59
1.6
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
665
4296
1.05
0.59
5.8
4.0
u/ml
0.3
0.3
0.21
372
2410
(3023436) Glucagon [Mass/volume] in Serum or Plasma
17
82
1.40
0.59
2.1
1.6
ng/l
191.7
203.2
0.19
17
66
(3033086) Enterovirus NOS Ab [Titer] in Serum
14
65
1.46
0.58
1.0
1.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
400
2880
0.94
0.58
1.5
2.0
titre
1226.7
3639.1
—
6
178
(3013862) HLA-DP [Type]
19
94
1.37
0.58
1.0
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
137
1031
0.90
0.58
1.6
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
104
623
1.13
0.57
2.0
2.3
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
110
838
0.89
0.57
1.4
1.5
%
8.7
3.8
0.85
17
204
(3020123) Porphyrins [Interpretation] in Serum or Plasma
22
112
1.33
0.57
1.1
1.1
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
10
43
1.58
0.57
6.5
5.5
mmol/l
0.2
0.2
—
10
43
(3011985) Renin [Units/volume] in Plasma
354
2556
0.94
0.57
1.5
1.6
mu/l
58.9
68.6
0.48
320
2312
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
277
1745
1.08
0.57
1.8
1.6
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
166
1023
1.10
0.56
1.3
1.2
u/l
18.8
21.3
0.29
145
893
(3034770) Mitochondria Ab [Titer] in Serum
869
5658
1.04
0.56
1.3
1.3
titre
1001.5
970.3
0.05
20
151
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
95
567
1.14
0.56
3.4
3.5
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
91
700
0.88
0.56
1.8
2.0
ug/min
101.1
128.2
0.13
22
158
(40763480) Human metapneumovirus Ag [Presence] in Specimen
17
83
1.39
0.56
1.2
1.6
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
29
247
0.80
0.55
2.9
2.5
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
22
113
1.32
0.54
1.0
1.2
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
9
41
1.49
0.54
2.0
1.4
mmol/24h
2.2
2.3
—
9
41
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
25
131
1.29
0.54
1.4
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
48
272
1.20
0.54
8.8
7.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
26948
182064
1.02
0.54
3.9
4.1
mmol/l
4.9
4.8
12.35
25816
172627
(3036180) Methadone [Presence] in Urine
6
67
0.61
0.53
1.2
3.1
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
9
42
1.45
0.53
1.1
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
19
170
0.76
0.53
1.0
1.1
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
43
349
0.83
0.53
1.6
1.4
g/l
27.4
24.2
0.59
31
253
(3023520) Reticulocytes [#/volume] in Blood
1543
10752
0.97
0.53
3.1
2.9
e9/l
71.6
71.9
0.10
1108
7907
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
310
1968
1.07
0.53
1.6
1.4
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
166
1028
1.09
0.52
2.1
1.8
u/field
1.9
1.9
0.01
85
529
(40760892) CBC W Ordered Manual Differential panel - Blood
6293
43182
0.98
0.52
3.9
4.6
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
52
413
0.85
0.51
1.2
1.3
g/l
39.2
39.7
0.07
31
228
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
89
679
0.89
0.50
1.4
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
89
679
0.89
0.50
1.4
1.5
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
69
407
1.15
0.50
6.9
8.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
319
2033
1.06
0.49
1.4
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
82
628
0.88
0.49
1.6
2.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
634
4480
0.96
0.48
2.2
2.2
g/l
10.1
10.2
0.08
538
3839
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
79
472
1.13
0.48
1.2
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
37
301
0.83
0.48
1.0
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
92
698
0.89
0.48
4.0
3.2
—
—
—
0
0
(3004268) Protein electrophoresis panel - Cerebral spinal fluid
7
32
1.48
0.47
1.1
1.2
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
74
568
0.88
0.47
1.3
1.7
iu/ml
—
422.8
—
0
8
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
656
4627
0.96
0.47
1.3
1.5
iu/ml
9.8
14.8
0.85
11
116
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
826
5799
0.96
0.46
1.6
1.6
titre
393.6
328.1
0.16
22
222
(21491868) Cryoglobulin [Mass/volume] in Serum
104
634
1.11
0.46
1.2
1.2
g/l
0.8
0.2
—
8
38
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
118
881
0.91
0.46
1.3
1.3
u/l
339.9
521.3
2.66
112
837
(3005988) Vibrio sp identified in Specimen by Organism specific culture
319
2039
1.06
0.46
1.4
1.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
1100
7683
0.97
0.46
11.5
11.6
mmol/l
24.1
24.3
1.52
1045
7260
(3024522) Salmonella sp identified in Specimen by Organism specific culture
322
2059
1.06
0.46
1.5
1.5
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
7
33
1.44
0.46
1.0
1.2
%
2.9
2.2
—
7
33
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
74
442
1.13
0.46
7.0
8.7
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
89
538
1.12
0.46
1.5
1.4
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
73
436
1.13
0.46
1.2
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
33
184
1.22
0.45
1.2
1.1
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
37
209
1.20
0.45
2.5
2.4
umol/l
1.2
1.3
1.08
32
194
(3044941) Cell count panel - Synovial fluid
385
2478
1.05
0.44
1.4
1.4
—
—
—
0
0
(4212803)
20
105
1.29
0.44
1.1
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
318
2036
1.06
0.44
1.4
1.5
—
—
—
0
0
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
38
216
1.19
0.44
1.1
1.0
u/ml
0.8
1.9
0.74
27
148
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
22
187
0.80
0.44
1.1
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
18
157
0.78
0.44
1.1
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
421
2993
0.95
0.44
1.7
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
1339
8837
1.03
0.44
5.7
5.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
131
812
1.09
0.43
2.0
2.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
131
812
1.09
0.43
2.0
2.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
131
812
1.09
0.43
2.0
2.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
131
812
1.09
0.43
2.0
2.1
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
26
142
1.24
0.43
1.3
1.3
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
73
438
1.13
0.43
1.2
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
328
2104
1.06
0.43
1.4
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
448
3179
0.95
0.43
3.0
3.5
—
—
—
0
0
(3025315) Body weight
19
164
0.78
0.43
3.8
4.2
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
34
275
0.84
0.43
1.1
1.2
mmol/l
5.4
7.7
—
7
60
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
392
2528
1.05
0.43
1.6
1.3
nmol/l
0.2
0.2
0.62
23
159
(3002621) Streptococcal DNAse B [Units/volume] in Serum
39
223
1.19
0.43
1.2
1.1
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
432
2793
1.05
0.43
3.8
3.6
u/ml
461.6
582.4
0.22
404
2538
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
175
1100
1.08
0.42
1.9
1.8
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
34
192
1.20
0.42
1.1
1.1
u/ml
6.6
10.9
0.85
24
123
(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid
0
11
0.00
0.42
0.0
2.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
58
448
0.88
0.42
2.3
3.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
58
448
0.88
0.42
2.3
3.1
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
642
4515
0.96
0.42
7.0
4.9
kpa
9.2
8.9
3.91
618
4245
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
12
0.00
0.41
0.0
1.1
—
31.7
—
0
12
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
90
549
1.11
0.41
2.3
1.8
umol/l
17.4
16.4
0.30
90
549
(3028707) Methadone [Presence] in Urine by Screen method
757
5306
0.97
0.41
2.2
3.2
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
34
193
1.19
0.41
1.1
1.1
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
5
23
1.47
0.40
1.0
1.0
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
166
1210
0.93
0.40
1.5
1.4
e6/l
3633.7
3899.2
0.09
110
889
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
7
72
0.66
0.40
1.0
1.1
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
12
59
1.38
0.40
1.2
1.0
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
27
150
1.22
0.40
1.0
1.1
u/ml
4.0
1.8
0.26
16
112
(3019977) pH of Arterial blood
104
773
0.91
0.40
2.2
2.8
ph
7.4
7.4
0.06
32
251
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
1212
8426
0.97
0.39
1.5
1.5
—
—
—
0
0
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
13
65
1.36
0.39
1.2
1.1
g/l
0.2
0.2
—
8
51
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
13
65
1.36
0.39
1.0
1.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
13
65
1.36
0.39
1.1
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
17
89
1.29
0.39
1.0
1.0
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
96
716
0.91
0.39
1.3
1.3
titre
49.2
83.5
0.64
12
55
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
138
863
1.08
0.39
2.9
2.4
umol/l
53.4
54.1
0.08
120
739
(4027681)
219
1394
1.06
0.39
1.2
1.3
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
2160
14365
1.02
0.39
9.3
9.2
%
96.5
95.9
4.23
2075
13870
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
192
1217
1.07
0.39
1.6
1.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
176
1277
0.93
0.38
2.4
2.1
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
13
116
0.76
0.38
3.1
3.2
—
—
—
0
0
(44806071)
45
264
1.16
0.38
1.0
1.1
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
26
145
1.22
0.37
1.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
334
2156
1.05
0.37
1.8
1.8
—
—
—
0
0
(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay
14
123
0.77
0.37
1.3
1.3
mg/l
1.6
1.7
—
8
107
(3033942) Copper [Moles/time] in 24 hour Urine
18
96
1.27
0.37
1.7
1.1
umol/24h
3.0
0.5
—
10
43
(3000475) Leukocytes [#/volume] in Synovial fluid
538
3783
0.96
0.37
1.7
1.7
e6/l
15673.1
11899.8
0.69
380
2765
(3009871) Measles virus Ab [Titer] in Serum
126
788
1.08
0.37
1.8
1.6
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
42
246
1.16
0.36
1.2
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
320
2065
1.05
0.36
1.4
1.5
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
72
438
1.11
0.36
1.2
1.2
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
34
269
0.86
0.35
4.4
3.5
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
53
317
1.13
0.35
1.2
1.3
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
65
394
1.12
0.35
2.8
2.6
mg/l
35.8
35.1
0.02
13
82
(3006184) Hemoglobin [Mass/volume] in Capillary blood
487
3427
0.96
0.35
2.1
2.2
g/l
134.5
134.2
0.09
353
2532
(3020630) Protein [Mass/volume] in Serum or Plasma
1538
10638
0.98
0.35
2.6
2.5
g/l
67.1
67.0
0.09
1433
9897
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
330
2340
0.96
0.34
1.3
1.4
pmol/l
309.4
322.8
0.24
246
1853
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
27
153
1.20
0.34
1.0
1.0
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
2363
15756
1.02
0.34
2.5
2.5
g/l
0.2
0.2
3.56
2244
14745
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
177
1126
1.07
0.34
1.2
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
59
447
0.89
0.34
1.7
2.0
—
—
—
0
0
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
14
73
1.30
0.34
1.5
1.6
u/l
0.0
0.1
—
5
20
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
14
73
1.30
0.34
3.6
3.5
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
47
280
1.14
0.34
1.8
1.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
619
4331
0.97
0.33
1.5
1.6
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
56
338
1.12
0.33
7.8
2.8
mmol/l
1.2
1.2
0.03
56
326
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
286
1848
1.05
0.33
1.2
1.2
u/l
82.4
67.4
0.59
202
1294
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
65
488
0.90
0.32
1.7
2.0
e6/l
5565.6
10590.9
0.42
29
253
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
155
1120
0.94
0.32
1.7
1.5
u/l
4.0
6.1
1.16
76
563
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
44
262
1.14
0.32
1.1
1.0
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
690
4814
0.97
0.32
2.1
2.2
g/l
7.0
7.3
3.25
537
3727
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
61
459
0.90
0.32
1.2
1.2
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
167
1064
1.06
0.31
1.3
1.2
u/l
82.3
94.6
0.78
148
946
(3027801) Oxygen [Partial pressure] in Arterial blood
2414
16116
1.02
0.31
8.7
8.6
kpa
13.6
12.9
7.03
2311
15452
(3037692) Legionella sp identified in Specimen by Organism specific culture
88
547
1.09
0.31
1.6
1.5
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
7
69
0.69
0.31
1.0
1.0
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
2415
16126
1.02
0.31
8.7
8.6
kpa
5.1
5.1
2.54
2314
15460
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
689
4803
0.97
0.31
2.1
2.2
g/l
3.9
3.8
0.20
515
3532
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
41
244
1.14
0.30
1.2
1.1
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
16
134
0.81
0.30
1.0
1.1
u/l
28.2
23.5
—
9
91
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
114
718
1.08
0.30
1.1
1.1
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
7
37
1.28
0.30
1.9
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
120
872
0.93
0.30
1.3
1.5
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
10
89
0.76
0.30
1.1
1.1
—
—
—
0
0
(4015189)
45
343
0.89
0.30
3.0
2.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
565
3712
1.03
0.30
1.2
1.2
u/ml
26.9
14.8
—
7
56
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
15
126
0.81
0.29
1.2
1.3
—
362.0
—
0
5
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
119
864
0.93
0.29
2.3
2.1
mg/l
9.3
9.2
0.01
98
684
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
99
621
1.08
0.29
2.2
2.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
690
4804
0.97
0.29
2.1
2.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
538
3534
1.03
0.29
1.1
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
206
1469
0.95
0.29
1.2
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
294
1909
1.04
0.29
1.4
1.4
titre
—
—
—
0
0
(4281824)
282
1830
1.04
0.29
1.1
1.2
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
134
967
0.94
0.28
1.5
1.6
nmol/l
2.8
6.1
0.68
96
805
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
381
2677
0.96
0.28
1.6
1.4
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
28
163
1.16
0.28
1.3
1.3
ml/s/173m2
1.8
1.4
0.50
19
120
(3022313) Gas panel - Capillary blood
1094
7567
0.98
0.28
5.2
4.4
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
26
205
0.86
0.28
1.8
2.7
mg/l
3.1
3.3
0.10
26
198
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
175
1251
0.95
0.27
4.1
4.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
390
2551
1.04
0.27
1.6
1.3
nmol/l
0.5
1.3
0.90
378
2471
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
118
854
0.94
0.27
1.3
1.5
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
96
604
1.08
0.27
1.1
1.1
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
257
1668
1.04
0.27
1.2
1.2
titre
60.0
218.8
—
9
51
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
61
453
0.91
0.26
1.3
1.3
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
5
49
0.69
0.26
1.0
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
639
4445
0.97
0.26
1.3
1.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
876
5806
1.02
0.26
1.3
1.3
titre
181.6
104.8
0.56
81
581
(3017315) Amylase [Enzymatic activity/volume] in Urine
136
977
0.94
0.26
1.2
1.3
u/l
281.3
329.1
0.34
124
913
(3044009) aPTT.lupus sensitive (LA screen)
32
190
1.14
0.26
1.2
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
115
731
1.07
0.25
1.1
1.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
1027
6822
1.02
0.25
5.2
4.6
mmol/l
24.5
24.7
1.45
975
6470
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
137
983
0.94
0.25
1.0
1.0
ng/l
301.6
346.3
0.52
102
746
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
289
2035
0.96
0.25
1.6
1.6
%
52.2
54.6
0.45
175
1309
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
96
697
0.93
0.25
1.8
1.8
au/ml
148.4
144.4
0.02
16
95
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
10
52
1.30
0.25
1.0
1.0
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
126
804
1.06
0.25
1.7
1.5
u/field
2.4
2.3
0.05
92
620
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
257
1672
1.04
0.25
1.2
1.2
titre
218.5
192.4
0.18
52
282
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
19
108
1.19
0.25
1.3
1.2
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
19
108
1.19
0.25
1.2
1.3
%
24.8
14.8
—
9
30
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
446
2932
1.03
0.25
1.6
1.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
181
1168
1.05
0.25
1.4
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
2411
16138
1.01
0.25
8.7
8.6
mmol/l
0.8
1.0
1.83
1928
12824
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
55
408
0.91
0.24
1.4
1.2
pmol/l
286.2
349.8
0.94
40
307
(3006442) Creatine [Moles/volume] in Serum or Plasma
208
1348
1.05
0.24
1.3
1.4
umol/l
69.2
71.0
0.17
18
131
(21494814) CD8 cells/100 lymphocytes in Specimen
103
744
0.94
0.24
2.0
2.1
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
83
604
0.93
0.24
1.2
1.3
%
20.0
19.8
0.01
11
98
(4010399)
1811
12442
0.99
0.24
1.4
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
60
373
1.09
0.23
1.3
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
103
655
1.07
0.23
1.6
1.8
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
87
550
1.07
0.23
1.9
1.9
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
5
26
1.30
0.23
1.0
1.0
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
25
194
0.87
0.23
7.3
6.3
%
59.5
69.9
0.89
17
158
(40768443) Skin Pathology biopsy report
1069
7116
1.02
0.23
1.2
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
239
1557
1.04
0.23
1.0
1.1
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
10
53
1.28
0.22
1.6
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
271
1771
1.04
0.22
3.3
2.6
—
—
—
0
0
(3004541) Aldosterone [Moles/volume] in Urine
0
7
0.00
0.22
0.0
1.3
—
—
—
0
0
(3027114) Cholesterol [Mass/volume] in Serum or Plasma
0
7
0.00
0.22
0.0
1.0
—
—
—
0
0
(36304079) Mucus [Presence] in Urine sediment
0
8
0.00
0.22
0.0
1.0
—
—
—
0
0
(3028917) Waxy casts [#/area] in Urine by Computer assisted method
0
9
0.00
0.21
0.0
1.0
—
—
—
0
0
(3030940) RBC casts [#/area] in Urine by Computer assisted method
0
9
0.00
0.21
0.0
1.0
—
—
—
0
0
(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma
0
9
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
19
110
1.17
0.21
1.0
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
1642
10980
1.01
0.21
1.7
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
866
5760
1.02
0.21
2.0
2.0
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
12
66
1.23
0.21
1.1
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
41
252
1.10
0.21
2.4
2.6
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
118
758
1.06
0.20
1.1
1.1
ng/l
1590.2
229.3
0.84
25
154
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
782
5401
0.98
0.20
2.7
2.5
ug/l
452.4
574.3
0.65
730
5024
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
23
136
1.15
0.20
1.2
1.3
u/l
32.8
342.8
0.82
16
103
(3042045) Bilirubin.total [Moles/volume] in Peritoneal fluid
0
10
0.00
0.20
0.0
1.4
—
114.3
—
0
10
(3003095) Rheumatoid factor [Units/volume] in Synovial fluid
0
10
0.00
0.20
0.0
1.0
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
42
259
1.10
0.20
1.2
1.1
pmol/l
3.9
2.7
—
6
42
(3017509) Phencyclidine [Presence] in Urine
45
333
0.92
0.20
1.2
2.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
57
417
0.93
0.20
1.2
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
58
364
1.08
0.19
3.7
2.8
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
24
184
0.88
0.19
1.6
1.9
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
76
549
0.94
0.19
1.1
1.2
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
139
986
0.96
0.19
1.0
1.0
ng/l
784.6
774.4
0.07
95
727
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
18
141
0.86
0.19
1.8
2.2
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
41
304
0.91
0.19
1.4
1.3
mmol/24h
96.1
82.5
—
7
6
(3006653) Thiamine [Moles/volume] in Blood
143
926
1.05
0.19
1.4
1.3
nmol/l
135.2
139.7
0.55
143
926
(3011436) Histone Ab [Units/volume] in Serum
48
353
0.92
0.19
1.0
1.1
u/ml
—
8.9
—
0
7
(3035947) Staphylolysin Ab [Units/volume] in Serum
122
867
0.95
0.18
1.1
1.1
iu/ml
3.6
3.7
—
9
79
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
41
254
1.09
0.18
1.0
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
94
672
0.95
0.18
1.0
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
154
1086
0.96
0.17
1.5
1.4
e6/l
64448.6
50292.3
0.17
85
648
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
113
730
1.05
0.17
1.2
1.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
326
2151
1.03
0.17
7.9
6.7
mg/l
10.8
10.6
0.31
309
2003
(3021788) Differential panel - Synovial fluid
431
2987
0.98
0.17
1.5
1.6
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
63
400
1.07
0.17
2.0
1.7
u/l
15.1
39.3
2.38
58
365
(3012095) Magnesium [Moles/volume] in Serum or Plasma
3859
25972
1.01
0.17
4.7
4.0
mmol/l
0.8
0.8
0.87
3651
24481
(3026029) Penicillin V IgE Ab [Units/volume] in Serum
11
89
0.84
0.16
1.0
1.0
u/ml
0.0
0.1
—
5
33
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
8
49
1.11
0.16
1.6
1.6
mg/l
8.4
3.7
—
8
44
(3016879) Cocaine [Presence] in Urine
1685
11534
0.99
0.16
1.8
2.3
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
26
195
0.90
0.16
1.1
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
563
3885
0.98
0.15
1.3
1.3
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
9
52
1.17
0.15
1.1
1.3
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
211
1474
0.97
0.15
2.6
2.9
mg/l
33.3
58.1
1.46
143
1037
(3014111) Lactate [Moles/volume] in Serum or Plasma
1971
13478
0.99
0.15
8.7
8.4
mmol/l
1.3
1.3
0.11
1896
12994
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
191
1253
1.03
0.15
1.2
1.2
u/ml
8.6
13.0
0.31
20
110
(40762814) Titanium [Mass/volume] in Blood
28
172
1.10
0.15
1.9
2.5
ug/l
3.2
5.4
—
8
53
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
31
192
1.09
0.15
1.1
1.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
151
988
1.04
0.14
3.1
2.2
umol/l
147.5
152.4
0.06
79
495
(3024471) HLA-A [Type]
133
868
1.04
0.14
1.0
1.0
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
34
212
1.09
0.14
1.0
1.1
u/ml
0.7
1.1
0.48
18
138
(3016650) Hepatitis A virus Ab [Presence] in Serum
552
3678
1.02
0.14
1.1
1.1
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
20
121
1.12
0.14
2.4
11.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
25809
175065
0.99
0.13
3.5
3.7
mmol/l
1.3
1.4
18.17
24598
164852
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
38
277
0.93
0.13
2.1
2.5
mmol/l
7.2
7.6
0.16
21
153
(3019174) dRVVT (LA screen)
29
180
1.09
0.13
1.2
1.2
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
51
367
0.94
0.13
1.5
1.4
mu/l
53.1
80.4
1.19
43
289
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
598
4114
0.98
0.13
2.2
2.3
g/l
0.8
0.7
0.43
536
3656
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
75
533
0.95
0.13
1.1
1.1
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
141
987
0.97
0.12
1.0
1.0
ng/l
39.8
42.2
0.25
103
733
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
344
2285
1.02
0.12
1.5
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
131
858
1.03
0.12
1.1
1.1
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
18
136
0.90
0.12
1.2
1.5
%
33.2
37.1
0.15
11
94
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
391
2698
0.98
0.12
1.3
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
627
4189
1.01
0.12
2.3
2.4
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
26
192
0.92
0.12
3.8
2.9
mg/l
1.6
1.2
0.25
16
119
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
126
883
0.97
0.12
1.1
1.2
u/l
19.8
23.7
0.52
104
682
(3036782) Glucose [Moles/volume] in Pleural fluid
147
1027
0.97
0.12
1.3
1.3
mmol/l
6.0
6.3
0.59
140
933
(3004616) Nuclear Ab [Presence] in Serum
306
2116
0.98
0.12
1.3
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
226
1495
1.02
0.12
1.3
1.4
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
21
129
1.10
0.11
2.0
1.5
umol/24h
350.7
307.5
0.63
21
129
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
19
116
1.11
0.11
1.1
1.3
—
—
—
0
0
(3015665) Acarus siro IgE Ab [Units/volume] in Serum
12
93
0.87
0.11
1.0
1.0
u/ml
0.6
0.2
—
6
46
(3036048) Francisella tularensis Ab [Titer] in Serum
76
493
1.04
0.11
1.1
1.2
titre
266.7
380.9
—
6
23
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
33
208
1.08
0.11
1.1
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
46
294
1.06
0.11
1.7
1.6
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
36
228
1.07
0.11
1.2
1.5
%
59.0
53.3
0.29
20
120
(3025549) Creatine [Moles/time] in 24 hour Urine
17
128
0.90
0.11
1.4
1.4
—
14.2
—
0
6
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
115
754
1.03
0.11
1.0
1.0
u/ml
8.0
12.8
0.49
14
92
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
766
5249
0.99
0.11
1.9
1.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
317
2186
0.98
0.10
1.7
1.6
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
19
117
1.10
0.10
2.1
5.9
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
19
141
0.91
0.10
1.2
1.2
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
15
113
0.90
0.10
4.4
8.1
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
16
120
0.90
0.10
6.6
9.9
e6/l
926.3
166.1
—
9
87
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
38
273
0.94
0.10
1.2
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
27155
183872
1.00
0.10
4.2
4.4
mmol/l
2.9
2.9
10.85
25850
173247
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
176
1165
1.02
0.10
1.1
1.1
u/l
1.0
1.1
1.86
81
530
(3012441) Differential panel - Pleural fluid
147
1022
0.97
0.09
1.4
1.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
3826
26030
1.00
0.09
3.1
2.9
mmol/l
2.4
2.4
1.89
3337
22909
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
127
884
0.97
0.09
1.1
1.2
u/l
77.0
84.6
0.79
104
715
(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid
16
98
1.11
0.09
1.1
1.4
%
1.1
1.1
—
10
66
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
195
1294
1.02
0.09
1.2
1.2
u/ml
47.6
65.5
0.40
13
61
(3016038) Potassium [Moles/volume] in Urine
147
972
1.02
0.09
1.3
1.6
mmol/l
39.2
33.5
2.00
136
860
(3007919) Fasciola sp Ab [Titer] in Serum
6
38
1.07
0.09
1.3
1.0
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
32
204
1.06
0.08
1.2
1.2
mmol/l
2.2
1.9
0.38
18
123
(3018851) Theophylline [Moles/volume] in Serum or Plasma
17
105
1.10
0.08
2.4
1.7
umol/l
40.2
46.6
0.64
17
105
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
31
223
0.94
0.08
1.2
1.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
30
216
0.94
0.08
1.2
1.1
—
—
—
0
0
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
5
43
0.79
0.08
2.0
2.1
—
—
—
0
0
(3020618) Glucose [Moles/volume] in Synovial fluid
5
44
0.77
0.08
1.4
1.1
mmol/l
4.9
4.8
—
5
28
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
5
44
0.77
0.08
3.0
4.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
2177
14825
0.99
0.08
3.3
3.0
%
1.7
1.8
1.31
1995
13400
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
193
1333
0.98
0.08
2.2
2.9
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
7
44
1.08
0.08
1.1
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
3104
21116
1.00
0.08
7.0
6.9
mmol/l
1.1
1.1
0.74
2934
19958
(3044416) Complement C4 [Mass/volume] in Pleural fluid
6
48
0.85
0.08
1.3
1.1
g/l
0.1
0.1
—
6
34
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
546
3737
0.99
0.07
2.1
2.1
g/l
39.0
38.4
1.68
491
3317
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
8
50
1.08
0.07
1.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
333
2227
1.01
0.07
1.5
1.3
nmol/l
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
210
1447
0.98
0.07
1.4
1.4
e6/l
61284.8
69180.0
0.08
131
1000
(3032333) Phosphate [Mass or Moles] in 24 hour Urine
8
53
1.02
0.07
1.0
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
15
111
0.92
0.07
2.0
1.8
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
9
56
1.09
0.07
1.1
1.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
215
1480
0.98
0.07
1.4
1.3
mmol/l
1.9
2.0
0.29
202
1369
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
548
3747
0.99
0.07
2.1
2.1
g/l
0.0
0.0
0.16
515
3478
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
49
345
0.96
0.07
1.7
2.5
mmol/l
1.2
1.5
0.43
30
259
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
195
1300
1.02
0.06
1.2
1.2
u/ml
36.7
47.1
0.29
15
98
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
22
159
0.94
0.06
1.5
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
155
1031
1.02
0.06
1.1
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
136
940
0.98
0.06
1.9
1.8
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
48
313
1.04
0.06
5.7
5.1
ug/min
31.7
46.4
0.76
32
246
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
134
926
0.98
0.06
2.1
2.4
ug/l
18.9
134.3
1.03
124
879
(3051387) C reactive protein [Mass/volume] in Capillary blood
491
3357
0.99
0.06
3.2
3.0
mg/l
24.2
25.3
0.26
279
2053
(40757494) Bilirubin.total [Moles/volume] in Blood
120
830
0.98
0.06
2.4
2.4
umol/l
38.0
58.2
0.67
18
96
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
16
100
1.08
0.06
1.0
1.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
112
775
0.98
0.06
1.4
1.4
u/ml
16.0
23.4
1.93
24
139
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
37
240
1.04
0.06
1.1
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
94
652
0.98
0.06
2.2
2.6
mmol/l
8.9
9.5
0.81
62
468
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
506
3400
1.01
0.06
2.1
2.2
g/l
0.0
0.0
0.00
474
3172
(3009677) Dengue virus Ab [Presence] in Serum
14
103
0.92
0.06
1.2
1.1
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
39
275
0.96
0.05
6.0
6.7
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
59
412
0.97
0.05
1.2
1.1
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
12
74
1.10
0.05
2.6
2.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
56
391
0.97
0.05
1.2
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
44
288
1.04
0.05
1.2
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
233
1597
0.99
0.05
1.7
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
1818
12276
1.00
0.05
1.8
2.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
143
984
0.98
0.05
1.8
1.7
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
198
1326
1.01
0.04
1.2
1.2
u/ml
69.2
48.6
0.44
18
54
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
98
676
0.98
0.04
1.2
1.2
u/l
14.2
15.0
0.17
90
625
(3023420) DNA double strand Ab [Units/volume] in Serum
313
2138
0.99
0.04
1.7
1.5
iu/ml
32.6
34.6
0.10
16
95
(1001926) Buprenorphine [Presence] in Urine by Screen method
1412
9599
1.00
0.04
1.8
2.4
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
94
648
0.98
0.04
2.1
2.1
ug/l
4.0
3.4
0.28
82
575
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
15
95
1.07
0.04
1.1
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
249
1702
0.99
0.03
1.6
1.7
mosm/kgh2o
282.8
281.8
0.31
200
1371
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
1268
8564
1.00
0.03
6.1
5.3
mmol/l
24.0
24.1
0.45
1166
7854
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
742
5050
1.00
0.03
2.1
2.2
mg/l
10.7
10.5
0.27
698
4761
(3027944) Amphetamines [Presence] in Urine
1796
12138
1.00
0.03
1.7
2.1
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
16
115
0.94
0.03
1.3
1.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
6970
47176
1.00
0.03
2.1
2.1
u/l
218.6
222.4
0.09
6646
44568
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
23
149
1.05
0.03
2.3
2.1
u/field
0.7
0.6
0.20
23
149
(3037756) Immunofixation for Serum or Plasma
353
2407
0.99
0.03
1.7
1.8
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
49
324
1.02
0.03
1.4
1.5
ng/l
64.7
63.8
0.01
27
215
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
211
1442
0.99
0.03
1.0
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
54
374
0.98
0.03
1.2
1.3
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
242
1652
0.99
0.03
1.9
2.0
mg/l
29.9
25.1
0.69
85
447
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
210
1434
0.99
0.02
1.0
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
1826
12351
1.00
0.02
1.8
2.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
123
825
1.01
0.02
1.9
1.8
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
134
900
1.01
0.02
4.5
4.9
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
140
956
0.99
0.01
1.5
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
1130
7670
1.00
0.01
1.6
1.6
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
121
813
1.01
0.01
1.1
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
1830
12387
1.00
0.01
1.8
2.2
—
—
—
0
0
(40758358) Immune stain study
11
70
1.06
0.01
1.0
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
31
215
0.98
0.01
1.1
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
1215
8239
1.00
0.00
2.3
3.3
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
73
499
0.99
0.00
7.7
5.9
—
—
—
0
0
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
18
119
1.02
0.00
1.2
1.6
%
14.1
12.7
0.06
12
89
(3007542) Rye IgE Ab [Units/volume] in Serum
17
117
0.98
0.00
1.0
1.1
u/ml
0.0
16.0
—
5
56
(3025577) Chromium [Mass/volume] in Blood
93
633
1.00
0.00
2.1
2.2
ug/l
3.6
2.3
0.80
80
532
(3042010) Triglyceride [Moles/volume] in Pleural fluid
25
168
1.01
0.00
1.2
1.3
mmol/l
0.4
1.6
2.14
14
114
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
110
747
1.00
0.00
3.0
3.0
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
18
125
0.98
0.00
1.1
1.1
u/l
7.3
12.0
1.08
18
125
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
144
972
1.00
0.00
1.1
1.1
u/ml
8.3
9.4
0.11
22
188
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
676
4583
1.00
0.00
2.1
2.2
g/l
3.0
3.0
0.23
526
3647
(3001729) Color of Synovial fluid
16
112
0.97
0.00
1.7
1.6
—
—
—
0
0
(3012898) Urea [Moles/volume] in Urine
29
198
0.99
0.00
1.2
1.6
mmol/l
180.3
173.9
0.08
29
184
(3018001) Oat IgE Ab [Units/volume] in Serum
25
170
1.00
0.00
1.0
1.0
u/ml
0.1
1.3
—
6
56
(3000012) Reticulocyte production index
106
720
1.00
0.00
1.3
1.5
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
508
3442
1.00
0.00
2.1
2.2
g/l
0.0
0.0
0.15
475
3180
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
13
86
1.02
0.00
1.0
1.1
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
5
38
0.89
0.00
2.6
3.1
mu/l
2.1
2.5
—
5
38
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
9
62
0.98
0.00
1.6
1.1
nmol/l
442.8
248.6
—
9
62
(3007147) Virus identified in Stool by Electron microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
9
61
1.00
0.00
1.0
1.3
—
—
—
0
0
(3017830) Gliadin IgG Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma
5
35
0.97
0.00
2.0
1.8
ng/l
67.9
9.5
—
5
29
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
6
45
0.90
0.00
1.3
1.6
—
—
—
0
0
(40771459) Voltage-gated potassium channel Ab [Moles/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(1175312) AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(1176058) AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006392) Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_CIRCUMSTANC_RELATED_REPRODUCTION – Persons encountering health services in circumstances related to reproduction
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).